Neuroprotective role of Ginkgobiloba and Rosuvastatin in ...
Gujarat Technological University Student list for M.Pharm ... student list_DP...validation for...
Transcript of Gujarat Technological University Student list for M.Pharm ... student list_DP...validation for...
Sr.
No.Date MAP_NUMBER Student_name sub code
Branch_
Code
College
_Code
Branch_
TypeBranch_name Micro
Other_
MicroDP1_TITLE Guide Name
1 29-April-2019 172020820002 Vashi Janu Alkeshkumar MRW403P 20 202 MP Pharmaceutics MULTIPARTICULATE
FORMULATION AND OPTIMIZATION OF ILEO-COLONIC TARGETED
MUCOADHESIVE MICROSPHERES CONTAINING FLURBIPROFEN FOR
TREATMENT OF ULCERATIVE COLITIS
DR. SAIKAT PANDE
2 02-May-2019 172020826001 PATEL KAJAL DHANJIBHAI MRW403P 26 202 MP Pharmacognosy HERBAL RESEARCHPHARMACOGNOSTICAL, PHYTOCHEMICAL AND DIURETIC ACTIVITY
OF RORIPPA INDICADR.(MRS) MONA KUKKAR
3 29-April-2019 172020820001PATEL VISHAKHAKUMARI
MAHESHKUMARMRW403P 20 202 MP Pharmaceutics
NANO SUSPENSION/EMULSION,
SEDDS, LIPID BASED DDS
SOLID SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM: A NOVEL
APPROACH FOR THE ORAL ADMINISTRATION OF POORLY WATER
SOLUBLE DRUG
DR. AJAY SOLANKI
4 29-April-2019 172020824001 PATEL TWINCYBEN KIRITBHAI MRW403P 24 202 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPTLC
METHOD FOR PERAMPANEL IN IT’S TABLET DOSAGE FORMDR. RAJENDRA MEHTA
5 29-April-2019 172020824002 THESIYA KRISHNABEN BHARATKUMAR MRW403P 24 202 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPTLC
METHOD FOR RIOCIGUAT IN TABLET DOSAGE FORM
DR.(MRS) ANANDKUMARI
D CAPTAIN
6 30-April-2019 172020822001 TARAPRA ANKITABEN MOHANBHAI MRW403P 22 202 MPPharmaceutical
ChemistryOTHER (KINDLY SPECIFY)
DESIGN, SYNTHESIS AND ANTI-ALZHEIMER ACTIVITY OF NOVEL
CHROMAN DERIVATIVESDR. VIPUL VAGHELA
7 29-April-2019 172050820001 Joshi Deepika Manohar MRW403P 20 205 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FABRICATION AND IN VITRO EVALUATION OF FEBUXOSTAT TABLET
FOR OBTAINING BIPHASIC DRUG RELEASE PROFILEDR. MUKESH GOHEL
8 29-April-2019 172050820005 PATEL KAJOLBEN ARUNKUMAR MRW403P 20 205 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
PREPARATION AND CHARACTERIZATION OF TOPICAL
FORMULATION CONTAINING QUERCETIN AS WOUND HEALING
PHYTOPHARMACEUTICAL
DR. VAISHALI THAKKAR
9 29-April-2019 172050820009 Udhwani Nikita Haresh MRW403P 20 205 MP Pharmaceutics MULTIPARTICULATE
EXPLORATION OF RESEARCH OPPORTUNITIES IN THE
DEVELOPMENT OF IMMEDIATE RELEASE MINI-TABLETS OF
CILOSTAZOL
DR. MUKESH C. GOHEL
10 29-April-2019 172050820010 Vyas Shubham Sanjaykumar MRW403P 20 205 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
DEVELOPMENT AND CHARACTERIZATION OF ROXITHROMYCIN
TOPICAL GELDR. VAISHLAI THAKKAR
11 29-April-2019 172050820002 MALAV RUPESH MANIAR MRW403P 20 205 MP Pharmaceutics
CO PROCESSED, DC,
TABLET/CAPSULE EXCIPIENTS AND
AT
DEVELOPMENT, CHARACTERIZATION AND EVALUATION OF DIBASIC
CALCIUM PHOSPHATE DIHYDRATE FOR THE FORMULATION OF
SOLID ORAL DOSAGE FORM
DR. MUKESH GOHEL
12 29-April-2019 172050820011 MS. PAROMITA SAHA MRW403P 20 205 MP Pharmaceutics
CO PROCESSED, DC,
TABLET/CAPSULE EXCIPIENTS AND
AT
MINIMIZATION OF RETARDATION OF DRUG RELEASE FROM HARD
GELATIN CAPSULE DR. MUKESH C. GOHEL
13 29-April-2019 172050820008 Tadvi Gaureeben Rajeshbhai MRW403P 20 205 MP Pharmaceutics OTHER (KINDLY SPECIFY)DEVELOPMENT OF DISINTEGRATION CONTROLLED MATRIX TABLET
OF GLIBENCLAMIDEMS. DIPIKA CHAVDA
14 29-April-2019 172050820003 Panchal Punam Ketankumar MRW403P 20 205 MP Pharmaceutics MISCELANEOUSDEVELOPMENT AND EVALUATION OF GLIPIZIDE PASTILLES BY
EMPLOYING QUALITY BY DESIGN APPROACHMR. HARDIK RANA
15 29-April-2019 172050820004 Patel Ashviniben Dilipbhai MRW403P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
DEVELOPMENT AND OPTIMIZATION OF ORAL SPRAY OF TADALAFIL
EMPLOYING QbD APPROACHMR. HARDIK RANA
16 29-April-2019 172050820006 Raut Jignasaben Devrambhai MRW403P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
DISSOLUTION ENHANCEMENT OF BOSWELLIA SERRATA EXTRACT
BY LIQUISOLID APPROACH MS. DIPIKA CHAVADA
17 29-April-2019 172050820007 Tadvi Arunaben Kanchanbhai MRW403P 20 205 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
DISSOLUTION ENHANCEMENT OF BICALUTAMIDE BY DEVELOPING
SOLID DISPERSION EMPLOYING MICROWAVE OVEN DR. VAISHALI T. THAKKAR
GTU/S19/DP-2/MPH-3074 Date:- 20-04-2019
Student list for M.Pharm Sem 4 (Regular) Dissertation Phase-2 (DP-2) (Summer 2019)Gujarat Technological University
18 29-April-2019 172050824004 PATEL KRISHNA SURESHBHAI MRW403P 24 205 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
FORMULATION DEVELOPMENT AND SIMULTANEOUS ESTIMATION
OF TADALAFIL AND DAPOXETINE HYDROCHLORIDE IN NEWER
COMBINED DOSAGE FORM USING QBD APPROACH
DR. PURVI A. SHAH
19 29-April-2019 172050824006 Shah Nejal Nitinkumar MRW403P 24 205 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR
QUANTIFICATION OF NEPAFENAC IN NEWER OPTIMIZED
OPHTHALMIC FORMULATION
DR. KALPANA G. PATEL
20 02-May-2019 172050825001 Himanshi Ravinder Kaul MRW403P 25 205 MP PharmacologyMETABOLIC DISORDER ( PLEASE
SPECIFY DISORDER)
EVALUATION OF ANTI-OBESITY ACTIVITY OF CORIANDRUM
SATIVUM IN RAT MODELDR. TEJAL R. GANDHI
21 02-May-2019 172050825003 NAIR KARISHMA JAYPRAKASH MRW403P 25 205 MP PharmacologyMETABOLIC DISORDER ( PLEASE
SPECIFY DISORDER)
EVALUATION OF NOX-4 INHIBITOR -QUERCETIN IN 10 WEEKS RAT
MODEL OF DIABETIC NEPHROPATHYDR. TEJAL R. GANDHI
22 29-April-2019 172050824002 Chunara Kiranben Rameshchandra MRW403P 24 205 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF EMPAGLIFLOZIN AND
METFORMIN HYDROCHLORIDE IN NEWER PHARMACEUTICAL
FORMULATION
DR. PURVI A. SHAH
23 29-April-2019 172050824003 DESAI JINAL HEMANTKUMAR MRW403P 24 205 MPPharmaceutical
Quality AssuranceHERBAL
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR
ESTIMATION OF BERBERINE AND RETINOIC ACID IN NOVEL HERBAL
FORMULATION USING EXPERIMENTAL DESIGN
DR.KALPANA G. PATEL
24 29-April-2019 172050824007 Shah Nischay Sunil MRW403P 24 205 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
FORMULATION DEVELOPMENT AND ANALYTICAL METHOD
DEVELOPMENT FOR FLUCONAZOLE AND QUERCETIN IN NOVEL
TOPICAL GEL FORMULATION
MR. HITESH G. RAVAL
25 02-May-2019 172050825004 PATEL ANJALIBEN BIPINBHAI MRW403P 25 205 MP Pharmacology RENAL DISORDERSEVALUATION OF SAPONIN RICH FRACTION OF FOLK MEDICINES FOR
THE TREATMENT OF KIDNEY STONE DISEASESDR. TEJAL R. GANDHI
26 02-May-2019 172050825005 Patel Priyankaben Pankajbhai MRW403P 25 205 MP Pharmacology CVS DISORDER
CARDIOPROTECTIVE EFFECT OF FOENICULUM VULGARE IN
ISOPROTERENOL INDUCED MYOCARDIAL INFARCTION IN
EXPERIMENTAL RATS
DR. TEJAL R. GANDHI
27 02-May-2019 172050825006 Prajapati Riddhi Bansilal MRW403P 25 205 MP Pharmacology RENAL DISORDERSEVALUATION OF FLAVANOID RICH FRACTION OF FOLK MEDICINES
IN EXPERIMENTALLY INDUCED UROLITHIASIS IN RAT MODELDR. TEJAL R. GANDHI
28 02-May-2019 172050825007 PUROHIT MILAP DAKSHESHKUMAR MRW403P 25 205 MP Pharmacology CVS DISORDERCARDIOPROTECTIVE EFFECT OF LANSOPRAZOLE IN
EXPERIMENTALLY INDUCED CARDIAC FIBROSISDR. SARIKA JOHARI
29 02-May-2019 172050825008 SINGH ANJALI JEEVANKUMAR MRW403P 25 205 MP Pharmacology CVS DISORDEREFFECT OF SERCA2 CHANNEL MODULATOR ON DIABETIC
CARDIOMYOPATHY IN RATSDR. TEJAL R. GANDHI
30 02-May-2019 172050825009 Vaibhav Hardikbhai Shah MRW403P 25 205 MP Pharmacology CVS DISORDERPREPARATION AND EVALUATION OF POLYHERBAL FORMULATION
FOR THE TREATMENT OF DIABETIC CARDIOMYOPATHYDR. TEJAL R. GANDHI
31 25-April-2019 172060820002 MALAVIYA VIKASKUMAR MADHUBHAI MRW403P 20 206 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION DEVELOPMENT AND EVALUATION OF
ONDANSETRON HCL EXTENDED RELEASE TABLETDR. MITTAL MAHESHWARI
32 25-April-2019 172060820001 Gokani Preet Nitinkumar MRW403P 20 206 MP Pharmaceutics MISCELANEOUSFORMULATION DEVELOPMENT AND EVALUATION OF
ACECLOFENAC LOADED EMULGELDR. MITTAL MAHESHWARI
33 25-April-2019 172060820003 Swati Adhikari MRW403P 20 206 MP Pharmaceutics MISCELANEOUSIMPACT OF HOLD TIME ON PHYSICAL PARAMETERS OF DRUG
PRODUCTDR. MITTAL MAHESHWARI
34 25-April-2019 172060824001 CHAUHAN SUDIKSHA RAMKUMAR MRW403P 24 206 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING RP-UPLC METHOD DEVELOPEMENT AND
VALIDATION FOR SIMULTANEOUS ESTIMATION OF ASPIRIN,
ROSUVASTATIN CALCIUM AND CLOPIDOGREL BISULPHATE IN
TABLET
DR. NEHA TIWARI
35 25-April-2019 172060824006 PATEL DIPALIBEN JAYANTIBHAI MRW403P 24 206 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING RP-UPLC METHOD DEVELOPEMENT AND
VALIDATION FOR OLMESARTAN MEDOXOMIL, CHLORTHALIDONE
AND CLINIDIPINE IN THEIR COMBINED TABLET DOSAGE FORM
DR. NEHA TIWARI
36 25-April-2019 172060824002 Dodiya Karan sinh Vajesangbhai MRW403P 24 206 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-
HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DIAZEPAM
AND DICYCLOMINE IN THEIR COMBINED TABLET
DR. PRAGNESH PATANI
37 25-April-2019 172060824003 GUPTA MONIKA HARERAM MRW403P 24 206 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPEMENT AND VALIDATION OF STABILITY INDICATING RP-
HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DOXOFYLLINE
AND ACEBROPHYLLINE IN THEIR COMBINE DOSAGE FORM
DR.PRAGNESH PATANI
38 25-April-2019 172060824004 MUDALIAR REVATI GANESHBHAI MRW403P 24 206 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ASSAY
RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF
DICYCLOMINE AND SIMETHICONE IN ITS PHARMACEUTICAL
DOSAGE FORM
DR. PRAGNESH PATANI
39 25-April-2019 172060824012 VAGHELA YAVANTIKA VIRENDRASINH MRW403P 24 206 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-
HPLC METHOD FOR THE ESTIMATION OF DAPAGLIFLOZIN IN ITS
TABLET DOSAGE FORM
DR. PRAGNESH PATANI
40 25-April-2019 172060824005 PATEL BHARGAVKUMAR PRADIPBHAI MRW403P 24 206 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF THE
SIMULTANEOUS ESTIMATION OF
TRIHEXYPHENIDYL,TRIFLUOPERAZINE AND THIORIDAZINE IN ITS
PHARMACEUTICAL DOSAGE FORM BY HPLC METHOD
MRS.VANITA MARVANIYA
41 25-April-2019 172060824007 PATEL YASH KANUBHAI MRW403P 24 206 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
ESTIMATION OF FORMOTEROL IN HUMAN PLASMA BY LC-MS/MS.MRS.VANITA MARVANIYA
42 25-April-2019 172060824011 VAGHELA AKSHAY PRAVINBHAI MRW403P 24 206 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING HPLC METHOD DEVELOPMENT AND
VALIDATION FOR SIMULTANEOUS DETERMINATION OF IBUPROFEN
AND HYDROCODONE BITARTRATE IN THEIR COMBINED DOSAGE
FORM
DR. NEHA TIWARI
43 26-April-2019 172070820002 PANDYA KHYATIBEN NITINKUMAR MRW403P 20 207 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
“FORMULATION AND EVALUTION OF BILAYERED BUCCAL TABLET
OF IVABRADINE HYDROCHLORIDE”DR. VISHNU M. PATEL
44 26-April-2019 172070820003 patel yaminibahen nikhilkumar MRW403P 20 207 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
“FORMULATION AND EVALUTION OF BUCCAL PATCH CONTAINING
DULOXETINE HYDROCHLORIDE FOR THE TREATMENT OF
DEPRESSION’’
DR. VISHNU M. PATEL
45 26-April-2019 172070820005 Vadaliwala Munavvarbanu Abdullatif MRW403P 20 207 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
DEVELOPMENT AND EVALUATION OF ORODISPERSIBLE TABLET OF
APIXABAN
DR. ANANDKUMAR
KANAIYALAL PATEL
46 26-April-2019 172070820001 MANSURI AKIBBHAI YASINBHAI MRW403P 20 207 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
DEVELOPMENT AND CHARACTERIZATION OF CONTROLLED RELEASE
MATRIX TABLET OF TIAGABINE HYDROCHLORIDE
DR. ANANDKUMAR
KANAIYALAL PATEL
47 25-April-2019 172080820003 PATEL DHRUV JAYNESHKUMAR MRW403P 20 208 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND EVALUATION OF FIXED DOSE GASTRO-
RETENTIVE BILAYER TABLET CONTAINING METFORMIN AS
SUSTAINED RELEASE AND SIMVASTATIN AS IMMEDIATE RELEASE.
DR. UPENDRA L PATEL
48 25-April-2019 172080820001 BHATT VIBHUTI DHIRENKUMAR MRW403P 20 208 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVISTUDY ON DISSOLUTION ENHANCEMENT OF EZETIMIBE DR. DASHRATH PATEL
49 25-April-2019 172080820002 DHRU KHUSHALI DARSHAKBHAI MRW403P 20 208 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
FORMULATION AND EVALUATION OF INTRANASAL DRUG DELIVERY
OF DIAZEPAM FOR STATUS EPILEPTICUS.DR. DASHRATH PATEL
50 25-April-2019 172080820004 RUPARELIYA KETA SHAILESHBHAI MRW403P 20 208 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
NASAL INSITU GEL OF ANTI-HIV DRUG FOR NOSE TO BRAIN DRUG
DELIVERY.DR. SUNITA CHAUDHARY
51 25-April-2019 172080824001 PANCHAL URVISHA GOVINDBHAI MRW403P 24 208 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING HPTLC METHOD DEVELOPMENT AND
VALIDATION OF DACLATASVIR DIHYDROCHLORIDE IN
PHARMACEUTICAL DOSAGE FORM
DR. RAGIN SHAH
52 25-April-2019 172080824004 PATEL NIDHIBEN VINODBHAI MRW403P 24 208 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND
VALIDATION OF DOFETILIDE IN CAPSULE DOSAGE FORMDR NISHA PARIKH
53 25-April-2019 172080824006 SHAH CHARMI RAJESH MRW403P 24 208 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND
VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF ILAPRAZOLE
AND LEVOSULPRIDE IN PHARMACEUTICAL DOSAGE FORM
MS JIGNASHA DERASARI
54 25-April-2019 172080824002 PARMAR MONIKA JAGDISHBHAI MRW403P 24 208 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND
VALIDATION OF S(-) AMLODIPINE BESYLATE AND
HYDROCHLOROTHIAZIDE IN BULK AND PHARMACEUTICAL DOSAGE
FORM
MR HIREN KADIKAR
55 25-April-2019 172080824003 PATEL BHOOMIKA VINODBHAI MRW403P 24 208 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND
VALIDATION OF DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR
DISOPROXIL FUMARATE IN ITS COMBINED DOSAGE FORM
MS MONA KAUSHAL
56 25-April-2019 172080824005 SAIYAD ANISH MIRSHABMIYA MRW403P 24 208 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION
FOR SIMULTANEOUS ESTIMATION OF EMTRICITABINE AND
TENOFOVIR ALAFENAMIDE IN TABLET DOSAGE FORM
DR JITENDRA PATEL
57 30-April-2019 172120820002 BHATT UKTI JANAKBHAI MRW403P 20 212 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
STUDIES IN APPLICATION OF HOT MELT EXTRUSION TECHNIQUE
FOR DEVELOPMENT OF DELAYED RELEASE FENOFIBRATE WITH
IMPROVED DISSOLUTION.
DR S R SHAH
58 30-April-2019 172120820005 CHUDASAMA TARUN RAMESHBHAI MRW403P 20 212 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND EVALUATION OF EXTENDED RELEASE TABLET
OF NIACIN.DR J R CHAVDA
59 30-April-2019 172120820006 GELHOR HIMANI BABUBHAI MRW403P 20 212 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND EVALUATION OF SUSTAINED RELEASE
FLOATING TABLET OF CINNARIZINE.DR D R BHIMANI
60 30-April-2019 172120820003 BHOLA JAYDIPKUMAR HAJABHAI MRW403P 20 212 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
LIQUISOLID TABLET OF EFAVIRENZ FOR IMPROVING DISSOLUTION
CHARACTERISTICS: DESIGN, DEVELOPMENT AND OPTIMIZATIONDR. M. M. SONIWALA
61 30-April-2019 172120820010 PATEL JETALBEN VASANTBHAI MRW403P 20 212 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
MEDICATED CHOCOLATE CONTAINING CEFIXIME TRIHYDRATE: A
NOVEL SOLID DOSAGE FORM FOR PEDIATRIC PATIENTS.K A PATEL
62 02-May-2019 172120825007 PATEL YASHIKAKUMARI ISHWARBHAI MRW403P 25 212 MP Pharmacology BABE STUDYBIOAVAILABILITY AND BIODISTRIBUTION STUDY OF RIFAXIMIN CO-
CRYSTALS IN RATSDR. RAVI A. MANEK
63 30-April-2019 172120820001 Bhanderi Brijesh Ashokbhai MRW403P 20 212 MP PharmaceuticsNANO SUSPENSION/EMULSION,
SEDDS, LIPID BASED DDS
DESIGN AND OPTIMIZATION OF LUTEIN LOADED SOLID LIPID
NANOPARTICLES FOR OPTHALMIC DELIVERYDR S R SHAH
64 30-April-2019 172120820004 CHRISTIAN PRAJAL MUKESHBHAI MRW403P 20 212 MP Pharmaceutics MULTIPARTICULATEFORMULATION AND EVALUATION OF LAFUTIDINE LIQUISOLID
PELLETS FOR ENHANCEMENT OF DISSOLUTION .DR J S PAUN
65 02-May-2019 172120825004 MAHETAR NAFISA USMANBHAI MRW403P 25 212 MP PharmacologyRESPIRATORY DISORDER ( PLEASE
SPECIFY DISORDER OR
EVALUATION OF ETHANOLIC EXTRACT OF BOERHAAVIA DIFFUSA L.
LEAVES ON OVALBUMIN INDUCED ASTHMA MODELDR. JIGNESH I. PATEL
66 02-May-2019 172120825008 VAGHASIYA TRUPTI PARSOTAMBHAI MRW403P 25 212 MP PharmacologyRESPIRATORY DISORDER ( PLEASE
SPECIFY DISORDER OR
EVALUATION OF EFFECT OF METHANOLIC EXTRACT OF TERMINALIA
CATAPPA L. IN EXPERIMENTAL ANIMAL MODEL OF ASTHMADR. DEVANG B. SHETH
67 30-April-2019 172120820008 MAVANI CHINTAN PRAVINBHAI MRW403P 20 212 MP Pharmaceutics
CO PROCESSED, DC,
TABLET/CAPSULE EXCIPIENTS AND
AT
DEVELOPMENT AND CHARACTERIZATION OF NOVEL CO-
PROCESSED EXCIPIENT OF TRICALCIUM CITRATE BY SPRAY DRYING.DR R D PARMAR
68 30-April-2019 172120820011 PRAJAPATI RAVIRAJ RAMESHKUMAR MRW403P 20 212 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
DESIGN AND EVALUATION OF TRANSDERMAL PATCH CONTAINING
GRANISETRON HYDROCHLORIDEDR. J M PATEL
69 30-April-2019 172120820012 PRAJAPATI URVASHI RAMESHBHAI MRW403P 20 212 MP Pharmaceutics
CO PROCESSED, DC,
TABLET/CAPSULE EXCIPIENTS AND
AT
PHYSICOCHEMICAL PROPERTY IMPROVEMENT OF CEFPODOXIME
PROXETIL BY CO PROCESSINGDR. JAYANT R. CHAVDA
70 30-April-2019 172120820013 SAKHIYA DHRUV CHANDRAKANTBHAI MRW403P 20 212 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
PREPARATION AND EVALUTION OF ITRACONAZOLE TOPICAL
NANOGELDR C H BORKHATARIYA
71 30-April-2019 172120820014 SANGHANI DIVYABEN VINODBHAI MRW403P 20 212 MP Pharmaceutics
CO PROCESSED, DC,
TABLET/CAPSULE EXCIPIENTS AND
AT
AUGMENTATION OF PHYSICOCHEMICAL PROPERTIES OF
CEFUROXIME AXETIL BY SPHERICAL AGGLOMERATION.DR R D PARMAR
72 02-May-2019 172120825005 MATHUR ANMOL CHETENDRAKUMAR MRW403P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)
EVALUATION OF ANTI-ARTHRITIC POTENTIAL OF METHANOLIC
EXTRACT OF WHOLE PLANT OF BIOPHYTUM SENSITIVUMIN
FREUNDS ADJUVANT INDUCED ARTHRITIS IN RATS
DR. JIGNESH I. PATEL
73 02-May-2019 172120825009 VAGHELA UJJVAL PARESHBHAI MRW403P 25 212 MP Pharmacology OTHER (KINDLY SPECIFY)
EFFECT OF ETHANOLIC EXTRACT OF PUERARIA TUBEROSA
(WILLD.)DC. TUBERS IN LETROZOLE INDUCED POLYCYSTIC OVARIAN
SYNDROME (PCOS) IN RATS
DR. DEVANG B. SHETH
74 30-April-2019 172120824001 Chavda Meghaben MRW403P 24 212 MPPharmaceutical
Quality AssuranceIMPURITY PROFILING
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR
ESTIMATION OF GENOTOXIC IMPURITIES IN RANOLAZINE API BY
GAS CHROMATOGRAPHY
DR. ASHOK B. PATEL
75 30-April-2019 172120824003 DHADUK AKTABEN RAMESHBHAI MRW403P 24 212 MPPharmaceutical
Quality AssuranceQUALITY RISK MANAGEMENT
QUALITY BY DESIGN APPROACH TO FIND DESIGN SPACE IN THE
DEVELOPMENT OF RP-HPLC METHOD FOR ESTIMATION OF
AMITRIPTYLINE HYDROCHLORIDE BY CENTRAL COMPOSITE DESIGN
(CCD)
MR. AJAY I. PATEL
76 30-April-2019 172120824002 CHOUDHARY JYOTISHNA BHOOPALSINGH MRW403P 24 212 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE
ESTIMATION OF ARTEMETHER AND LUMEFANTRINE IN MARKETED
FORMULATION BY UPLC
DR. ASHOK B. PATEL
77 30-April-2019 172120824010 MODH JAIVIK HITESHKUMAR MRW403P 24 212 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR
ESTIMATION OF DICLOFENAC DIETHYLAMINE TOPICAL SOLUTION
BY RP-HPLC METHOD
DR. NILESH K. PATEL
78 30-April-2019 172120824012 PATEL KRUPALIBEN JAGADISHBHAI MRW403P 24 212 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
SIMULTANEOUS ESTIMATION OF DAPAGLIFLOZIN PROPANEDIOL
MONOHYDRATE & METFORMIN HCL IN BULK AND TABLET DOSAGE
FORM USING UPLC
DR.AMITKUMAR J .VYAS
79 30-April-2019 172120824013 PATEL RUPALBEN ASHOKBHAI MRW403P 24 212 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ASSAY
METHOD FOR SIMULTANEOUS ESTIMATION OF AMLODIPINE
BESYLATE AND CELECOXIB IN SYNTHETIC MIXTURE BY RP-HPLC
DR. ASHOK B. PATEL
80 30-April-2019 172120824005 JANI SHIVANI NILESHKUMAR MRW403P 24 212 MPPharmaceutical
Quality AssuranceREGULATORY AFFAIRS
STUDY OF REGULATORY REQUIREMENTS FOR PHARMACEUTICALS
IN NON-EUROPEAN UNION MEMBER STATES KOSOVO, UKRAINE
AND SERBIA
DR. NILESH K. PATEL
81 30-April-2019 172120824006 JETHAVA PALAKBEN NANDLALBHAI MRW403P 24 212 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
EVALUATION OF INSTABILITY ISSUE IN PAEDIATRIC DRY SYRUP OF
CEPHALOSPORIN ANTIBIOTIC IN COMBINATION WITH CLAVULANIC
ACID
DR. NILESH K. PATEL
82 30-April-2019 172120824007 KATESHIYA GOVIND AMRUTLAL MRW403P 24 212 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
SIMULTANEOUS ESTIMATION OF NAPROXEN AND
DIPHENHYDRAMINE IN K3EDTA HUMAN PLASMA BY USING LC-ESI-
MS/MS
MR. AJAY I. PATEL
83 30-April-2019 172120824008 KHATRI AKSHALIBEN RAMCHANDRA MRW403P 24 212 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
ESTIMATION OF DOFETILIDE IN KȝEDTA HUMAN PLASMA BY USING
LC-ESI-MS/MS
MR. AJAY I. PATEL
84 30-April-2019 172120824009 KULKARNI POOJA CHANDRAKANT MRW403P 24 212 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
ESTIMATION OF DOSULEPIN HYDROCHLORIDE IN KʒEDTA HUMAN
PLASMA BY USING LC-ESI-MS/MS
DR.AMITKUMAR J .VYAS
85 30-April-2019 172120824011 PARMAR ANKUR MOHANBHAI MRW403P 24 212 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
ESTIMATION OF VARENICLINE TARTRATE USING KʒEDTA HUMAN
PLASMA BY LC-ESI-MS/MS
DR. ASHOK B. PATEL
86 30-April-2019 172120824015 SHARMA JIGNASHA KRUSHNAKANT MRW403P 24 212 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
ESTIMATION OF FLUCYTOSINE IN KȝEDTA HUMAN PLASMA BY
USING LC-ESI-MS/MS
DR.AMITKUMAR J .VYAS
87 29-April-2019 172130820007 SHAH HARDIK SANJAYKUMAR MRW403P 20 213 MP PharmaceuticsVESICULAR DRUG DELIVERY
SYSTEM
DEPOFOAM TECHNOLOGY BASED INTRAMUSCULAR DRUG
DELIVERY OF PREDNISOLONE ACETATE FOR TREATMENT OF
RHEUMATOID ARTHRITIS
DR.PRACHI PANDEY
88 29-April-2019 172130820004 PATEL DHRUVI KAMLESHBHAI MRW403P 20 213 MP Pharmaceutics
CO PROCESSED, DC,
TABLET/CAPSULE EXCIPIENTS AND
AT
PREPARATION AND CHARACTERIZATION OF SPRAY DRIED SOLID
DISPERSION OF AN ANTI-DIABETIC DRUG FOR DISSOLUTION
ENHANCEMENT
DR. NAAZNEEN SURTI
89 02-May-2019 172130825004 NEMADE MRUNALI ASHOK MRW403P 25 213 MP Pharmacology BABE STUDY
COGNITION ASSESSMENT AMONG INDIAN PATIENTS WITH HEAD
AND NECK CANCER USING PROMIS AND ICCTF RECOMMENDED
TESTS
DR. DEEPTI K. JANI
90 02-May-2019 172130825005 PANDEY RASHI SURESHKUMAR MRW403P 25 213 MP Pharmacology BABE STUDYBIOEQUIVALENCE STUDY OF FESOTERODINE FUMARATE
PROLONGED RELEASE TABLETS 8 MG IN FASTING CONDITIONSDR. DIGVIJAYSINH G. RANA
91 02-May-2019 172130825006 PARMAR MOHINI DHARMENDRASINH MRW403P 25 213 MP Pharmacology BABE STUDYBIOEQUIVALENCE STUDY OF FESOTERODINE FUMARATE
PROLONGED RELEASE TABLETS 8 MG IN FED CONDITIONSDR. DEEPTI K. JANI
92 29-April-2019 172130820001 KM SHALINI SHARMA MRW403P 20 213 MP Pharmaceutics OTHER (KINDLY SPECIFY)
CYCLODEXTRIN BASED NANOSPONGES: AN EFFECTIVE METHOD
FOR DISSOLUTION ENHANCEMENT OF LOW SOLUBILITY
NUTRACEUTICAL
DR ASHOK MAHAJAN
93 29-April-2019 172130820002 MISTRY JHEEL RAJUBHAI MRW403P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND EVALUATION OF NANOEMULSION BASED IN-
SITU GEL FOR OCULAR DRUG DELIVERY OF ACECLOFENACDR.PRIYAL PATEL
94 29-April-2019 172130820005 PATEL VAISHNAVIBEN PRAVINBHAI MRW403P 20 213 MP Pharmaceutics OTHER (KINDLY SPECIFY)VAGINAL DRUG DELIVERY SYSTEM OF METHOTREXATE FOR
TREATMENT OF RHEUMATOID ARTHRITISDR. NAAZNEEN SURTI
95 29-April-2019 172130820008 TELI ANJALIBEN KUSHALCHANDRA MRW403P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
DEVELOPMENT OF TARGETED FORMULATION OF BUDESONIDE FOR
INFLAMMATORY BOWEL DISEASE MANAGEMENTDR. MANISHA S. LALAN
96 29-April-2019 172130820009 TRIVEDI RUSHI JAWAHARLAL MRW403P 20 213 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND EVALUATION OF INTRANASAL IN-SITU GEL OF
PRAMIPEXOLE DIHYDROCHLORIDEDR.MEENAKSHI PATEL
97 29-April-2019 172130820003 NAZIYA ILYAS GHEEWALA MRW403P 20 213 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
SPRAY DRIED SOLID DISPERSION : AN EFFICIENT METHOD FOR
DISSOLUTION ENHANCEMENT OF NEVIRAPINEDR ASHOK MAHAJAN
98 29-April-2019 172130820006 PATEL VRUNDA SANJAYKUMAR MRW403P 20 213 MP Pharmaceutics MISCELANEOUSPREPARATION AND EVALUATION OF DRY POWDER INHALER
FORMULATION FOR PULMONARY DELIVERY OF CEFTAZIDIME.DR.PRIYAL PATEL
99 02-May-2019 172130825002 MAYUR WANKHADE MRW403P 25 213 MP Pharmacology OTHER (KINDLY SPECIFY)NUTRACEUTICAL INTERVENTIONS IN PACLITAXEL- INDUCED
NEUROPATHIC PAIN: AN EXPERIMENTAL STUDYDR. DEEPTI K. JANI
100 29-April-2019 172130824008 UPADHYAY KHYATIBEN VIJAYKUMAR MRW403P 24 213 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC
METHOD FOR ESTIMATION OF FIMASARTAN POTASSIUM
TRIHYDRATE IN PRESENCE OF ITS RELATED SUBSTANCES
DR. DIMAL SHAH
101 29-April-2019 172130824001 JOSHI KRUPABEN PRAVINBHAI MRW403P 24 213 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR
THE ESTIMATION OF FLIBANSERIN IN THE PRESENCE OF ITS
RELATED SUBSTANCE
DR. FALGUN A. MEHTA
102 29-April-2019 172130824003 NAIR SHREYA RADHAKRISHNAN MRW403P 24 213 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR
THE ESTIMATION OF POLMACOXIB IN PRESENCE OF ITS RELATED
SUBSTANCES.
DR. FALGUN A. MEHTA
103 29-April-2019 172130824004 PANCHAL PRACHI VISHNUKUMAR MRW403P 24 213 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR
THE ESTIMATION OF NETUPITANT IN THE PRESENCE OF ITS
RELATED SUBSTANCE
DR. FARHATJAHAN SHAIKH
104 02-May-2019 172130825001 KUNDU SMITA SUMANKUMAR MRW403P 25 213 MP Pharmacology CNS DISORDEREVALUATION OF ACTIVITY OF LOXOPROFEN IN VARIOUS ANIMAL
MODELS OF DEPRESSIONDR. DIGVIJAYSINH G. RANA
105 02-May-2019 172130825003 Mitra Pratik Sapan MRW403P 25 213 MP Pharmacology CNS DISORDEREVALUATION OF ACTIVITY OF TERIFLUNOMIDE IN VARIOUS ANIMAL
MODELS OF DEPRESSIONDR. DIGVIJAYSINH G. RANA
106 02-May-2019 172130825007 PATEL RUTU MANOJKUMAR MRW403P 25 213 MP Pharmacology CNS DISORDEREVALUATION OF ACTIVITY OF MONTELUKAST IN VARIOUS ANIMAL
MODELS OF DEPRESSIONDR. DIGVIJAYSINH G. RANA
107 29-April-2019 172130824002MIRZA NILAMFATEMA
MOHAMMADASKARIMRW403P 24 213 MP
Pharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF PITAVASTATIN CALCIUM AND
EZETIMIBE FROM ITS COMBINED TABLET DOSAGE FORM
DR. VANDANA B. PATEL
108 29-April-2019 172130824005 PARMAR PAYAL MAHESHBHAI MRW403P 24 213 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
ESTIMATION OF VALBENAZINE TOSYLATE IN BULKDR. VANDANA B. PATEL
109 29-April-2019 172130824006 PRAJAPATI DHRUVI ANILKUMAR MRW403P 24 213 MPPharmaceutical
Quality AssuranceIMPURITY PROFILING
DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR
ANALYSIS OF ALOGLIPTIN BENZOATE IN THE PRESENCE OF ITS
RELATED SUBSTANCES
DR. SHAILESH KORADIA
110 29-April-2019 172130824007 TAHILRAMANI POOJA JAGDISH MRW403P 24 213 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF UV AND CHROMATOGRAPHIC
METHODS FOR ESTIMATION OF MIRABEGRON AND SOLIFENACIN
SUCCINATE IN COMBINATION
DR. DIMAL SHAH
111 01-May-2019 172150820001 HITESH SANJAY BAKAS MRW403P 20 215 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND DEVELOPMENT OF RAFT FORMING FLOATING
DRUG DELIVERY SYSTEM FOR DOMPERIDONE SUSTAIN DRUG
RELEASE
MR VINOD RAMANI
112 01-May-2019 172150820002 PARMAR HIRENKUMAR NARANBHAI MRW403P 20 215 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
To Study the effect of hydro-alcoholic media on drug release
behavior of extended release tablet containing metoprololMR VINOD RAMANI
113 01-May-2019 172150820004 YADAV AJAY CHHOTELAL MRW403P 20 215 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND DEVELOPMENT OF IN SITU GEL CONTAINING
LEVOFLOXACIN LOADED LIPOSOME FOR PERIODONTITISMR. R. SENTHIL KUMAR
114 01-May-2019 172150824002 GUPTA VANDANA BARJENDRA MRW403P 24 215 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
FLUPIRTINE MALEATE AND TRAMADOL HYDROCHLORIDE IN
SYNTHETIC MIXTURE
DR. ZARNA DEDANIA
115 01-May-2019 172150824003 KERIWALA TEJAL MANOJKUMAR MRW403P 24 215 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF UV SPECTROSCOPIC AND
HPLC METHODS FOR LULICONAZOLE AND BECLOMETHASONE
DIPROPIONATE IN COMBINED PHARMACEUTICAL DOSAGE FORM.
DR. GHANSHYAM
SHANGHANI
116 01-May-2019 172150824005 SHAH ABHISHEKKUMAR BHARATKUMAR MRW403P 24 215 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF UV SPECTROSCOPIC AND
HPLC METHODS FOR ZONISAMIDE AND CILOSTAZOL IN SYNTHETIC
MIXTURE.
DR. ZARNA DEDANIA
117 01-May-2019 172150824004 PRAJAPATI RICHA ATULBHAI MRW403P 24 215 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
QBD APPROACH TO HPLC METHOD DEVELOPMENT AND
VALIDATION FOR THE ESTIMATION OF FLUOXETINE
HYDROCHLORIDE AND OLANZAPINE IN PHARMACEUTICAL DOSAGE
FORM.
DR. ZARNA DEDANIA
118 01-May-2019 172150824001 CHISTI ZENAB MOHD MASOOD MRW403P 24 215 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
HPTLC method development and validation of Naproxen Sodium
and Esomeprazole Magnesium Trihydrate in combined dosage
form.
DR. ZARNA DEDANIA
119 29-April-2019 172150827001 BHANDARI KRISHNA KAUSHIKKUMAR MRW403P 27 215 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
CURRENT REGULATORY REQUIREMENT FOR EXPORT OF SOLID
ORAL DOSAGE FORM IN BRAZIL AND MEXICODR .VINEET JAIN
120 29-April-2019 172150827002 Chaudhary Reena Bhagawanswaroop MRW403P 27 215 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
GUIDELINES AND REGULATORY REQUIREMENTS FOR LABELLING
AND PACKAGING OF INJECTIONS IN USA, EUROPE, INDIA AND
CANADA.
DR. RONAK DEDANIA
121 29-April-2019 172150827003 Dobariya Janki Rasikkumar MRW403P 27 215 MPPharmaceutical
Regulatory AffairsSIMULTENEOUS ESTIMATION
A COMPREHENSIVE STUDY ON REGULATORY REQUIREMENTS FOR
PRODUCT REGISTRATION OF VACCINES IN USA, EUROPE AND
CANADA.
DR. RONAK DEDANIA
122 29-April-2019 172150827004 Juneja Parul jitender MRW403P 27 215 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
REGULATORY GUIDELINES OF HAZARD ANALYSIS CRITICAL
CONTROL POINT (HACCP) WITH COMPREHENSIVE STUDY ON
STANDARDS AND CERTIFICATION PROCEDURES IN USA, AUSTRALIA
AND INDIA IN RELEVANCE TO PHARMA INDUSTRY
DR. RONAK DEDANIA
123 29-April-2019 172150827005 MAHLA SWETA MAVJIBHAI MRW403P 27 215 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
A COMPARATIVE STUDY OF REGULATORY REQUIREMENTS AND
GUIDELINES FOR MEDICAL DEVICES IN USA,JAPAN AND CANADADR. RONAK DEDANIA
124 29-April-2019 172150827008 TAILOR BRINDA ASHISHKUMAR MRW403P 27 215 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
CURRENT STATUS OF GENERIC DRUG APPROVAL PROCESS IN
UNITED STATES OF AMERICA AND EUROPEAN UNIONDR .VINEET JAIN
125 29-April-2019 172150827009YADAV KUSUM KUMARI SHREE DINESH
KUMARMRW403P 27 215 MP
Pharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
NAVIGATING REGULATORY FRAMEWORK TO DEFEAT ZIKA VIRUS IN
USA AND EUDR .VINEET JAIN
126 29-April-2019 172230828002 KAPADIA DHWANI PREYAS MRW403P 28 223 MPPharmaceutical
Technology
BUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
FORMULATION AND CHARACTERIZATION OF LIPOSOME BASED
INTRA-NASAL DELIVERY OF ARIPIPRAZOLE
DR. ALIASGAR J
KUNDAWALA
127 29-April-2019 172230828001 DESAI ANJALI DATTATRAY MRW403P 28 223 MPPharmaceutical
TechnologyOTHER (KINDLY SPECIFY)
DEVELOPMENT AND EVALUATION OF SPRAY DRIED INHALABLE DRY
POWDER OF POSACONAZOLE FOR PULMONARY ASPERGILLOSIS
DR. ALIASGAR J
KUNDAWALA
128 29-April-2019 172230823002 Patel Keshaben Manojbhai MRW403P 23 223 MPPharmaceutical
AnalysisOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
THE QUANTIFICATION OF MACITENTAN IN BULK AND
PHARMACEUTICAL DOSAGE FORM
DR. USMANGANI K.
CHHALOTIYA
129 29-April-2019 172230823003 YADAV PREETIBEN NARESHKUMAR MRW403P 23 223 MPPharmaceutical
AnalysisOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC AND UV-
VISIBLE SPECTROSCOPIC METHODS FOR QUANTIFICATION OF
MIRABEGRON IN BULK AND PHARMACEUTICAL DOSAGE FORM
DR. USMANGANI K.
CHHALOTIYA
130 25-April-2019 172240824001 CHAUDHARY RAJESHBHAI BHIKHABHAI MRW403P 24 224 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING HPLC METHOD DEVELOPMENT AND
VALIDATION FOR SIMULTANEOUS ESTIMATION OF
SERTACONAZOLE NITRATE AND BECLOMETHASONE DIPROPIONATE
IN ITS PHARMACEUTICAL DOSAGE FORM
DR. HIRAL PANCHAL
131 25-April-2019 172240824002 DAMSIYA NIKHIL KARSHANBHAI MRW403P 24 224 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING HPLC METHOD DEVELOPMENT AND
VALIDATION FOR SIMULTANEOUS ESTIMATION OF BENIDIPINE
HYDROCHLORIDE AND CHLORTHALIDONE IN ITS PHARMACEUTICAL
DOSAGE FORM
DR. HIRAL PANCHAL
132 26-April-2019 172250820003 Patel Bhaveshkumar Amrutlal MRW403P 20 225 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASALFORMULATION AND EVALUATION OF BUCCAL FILMS OF PIRIBEDIL DR. SHAILESH T. PRAJAPATI
133 26-April-2019 172250820006 PATEL RAJAT BHARATBHAI MRW403P 20 225 MP Pharmaceutics MULTIPARTICULATEFORMULATION AND EVALUATION OF SUSTAINED RELEASE
MICROSPHERES OF ITOPRIDE HYDROCHLORIDE DR. KEYUR S. PATEL
134 26-April-2019 172250820008 PATEL VRUNDABEN CHHGANBHAI MRW403P 20 225 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION AND EVALUATION OF SUBLINGUAL FILM OF
IVABRADINE HYDROCHLORIDEDR. KEYUR S. PATEL
135 26-April-2019 172250820002 KANSAGARA AMEEBEN RAMNIKBHAI MRW403P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND EVALUATION OF COLON TARGETED TABLETS
OF ELUXADOLINEDR. SHAILESH T. PRAJAPATI
136 26-April-2019 172250820004 PATEL JASMINABAHEN VISHNUBHAI MRW403P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX
TABLETS OF NATEGLINIDEDR. SHAILESH T. PRAJAPATI
137 26-April-2019 172250820005 PATEL NILESHKUMAR MUKESHBHAI MRW403P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND EVALUATION OF GASTRORETENTIVE
MUCOADHESIVE TABLETS OF RANOLAZINEDR. KEYUR S. PATEL
138 26-April-2019 172250820007 PATEL SUMIT RAJESHBHAI MRW403P 20 225 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND EVALUATION OF FLOATING TABLETS OF
PROPAFENONE HYDROCHLORIDEDR. KEYUR S. PATEL
139 26-April-2019 172250824002 HIRAPARA FENIBEN JAYANTILAL MRW403P 24 225 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING HPLC METHOD DEVELOPMENT AND
VALIDATION OF AMOXYCILLIN AND CLAVULANIC ACID IN TABLETDr. SAMIR C. PATEL
140 26-April-2019 172250824004 KACHCHHI RIDDHI RAMESHBHAI MRW403P 24 225 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING CHROMATOGRAPHIC METHOD
DEVELOPMENT AND VALIDATION OF SERTACONAZOLE NITRATE
AND ZINC PYRITHIONE IN SHAMPOO
DR. DEEPA R. PATEL
141 26-April-2019 172250824006 PATEL LAVINA GHANSHYAMBHAI MRW403P 24 225 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING CHROMATOGRAPHIC METHOD
DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS
ESTIMATION OF FLUCONAZOLE AND BECLOMETHASONE
DIPROPIONATE IN CREAM
DR. DEEPA R. PATEL
142 26-April-2019 172250824007 PATEL PINKI RANCHHODBHAI MRW403P 24 225 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING CHROMATOGRAPHIC METHOD
DEVELOPMENT AND VALIDATION OF ENROFLOXACIN AND
BROMHEXINE HCI IN COMBINED DOSAGE FORM
DR. DEEPA R. PATEL
143 26-April-2019 172250824008 SK MOTIUR RAHAMAN MRW403P 24 225 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING CHROMATOGRAPHIC METHOD
DEVELOPMENT AND VALIDATION OF BETAHISTINE
DIHYDROCHLORIDE AND DOMPERIDONE IN COMBINED DOSAGE
FORM
Dr. SAMIR C. PATEL
144 26-April-2019 172250824009 VYAS RAMA SHIVKUMAR MRW403P 24 225 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING HPLC METHOD FOR STIMULTANEOUS
ESTIMATION OF SERTACONAZOLE AND BECLOMETHASONE IN
THEIR COMBINED DOSAGE FORM
DR. DEEPA R. PATEL
145 26-April-2019 172250824001 Dhruv Nikita Mahendrakumar MRW403P 24 225 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR
SIMULTANEOUS ESTIMATION OF BENIDIPINE HCL, TELMISARTAN
AND CHLORTHALIDONE IN TABLET DOSAGE FORM
DR. DEEPA R. PATEL
146 26-April-2019 172250824005 PANCHAL HINABEN HASUBHAI MRW403P 24 225 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS
ESTIMATION OF TRIHEXYPHENIDYL, THIORIDAZINE AND
TRIFLUOPERAZINE IN ITS PHARMACEUTICAL DOSAGE FORM BY
HPLC
DR. DEEPA R. PATEL
147 26-April-2019 172250824003 JAIN JUHI ANILKUMAR MRW403P 24 225 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING CHROMATOGRAPHIC METHOD
DEVELOPMENT AND VALIDATION OF BENIDIPINE HYDROCHLORIDE
AND CHLORTHALIDONE IN TABLET
DR. DEEPA R. PATEL
148 25-April-2019 172280820001 BHAVSAR JAINI PANKAJKUMAR MRW403P 20 228 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION, DEVELOPMENT AND EVALUATION OF CONTROLLED
RELEASE TABLET OF TENELIGLIPTIN HYDROBROMIDE HYDRATEDR. YAMINI SHAH
149 25-April-2019 172280820009 Shah Pahini Jigarbhai MRW403P 20 228 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION, OPTIMIZATION AND EVALUATION OF CONTROLLED
RELEASE TABLETS OF LORCASERIN HYDROCHLORIDEDR. MANISH P. PATEL
150 25-April-2019 172280820005 NAMIT GUPTA MRW403P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVIMOUTH DISSOLVING FILMS OF NARATRIPTAN HYDROCHLORIDE DR. MANISH P. PATEL
151 25-April-2019 172280820007 Patel Het Suryakantbhai MRW403P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION, DEVELOPMENT AND EVALUATION OF ORAL
DOSAGE FORM OF RISEDRONATE SODIUMDR. PRAFUL BHARADIA
152 25-April-2019 172280820003 JAHNAVI BHARGAV JANI MRW403P 20 228 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
FORMULATION, DEVELOPMENT AND EVALUATION OF TOPICAL
PREPARATION OF LUTEIN DR. PRAFUL BHARADIA
153 25-April-2019 172280820004 MANAN VISHNUBHAI PATEL MRW403P 20 228 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
FORMULATION AND DEVELOPMENT OF ORAL TRANSMUCOSAL
DELIVERY SYSTEM OF AN ANTI-MIGRAINE AGENTDR. RADHIKA PANDYA
154 25-April-2019 172280820006 PATEL GRUSHA SANJAYKUMAR MRW403P 20 228 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
FORMULATION, DEVELOPMENT AND EVALUATION OF
SPIRONOLECTONE GEL FOR TREATMENT OF ANDROGENIC
ALOPECIA
DR. PRAFUL BHARADIA
155 25-April-2019 172280820002 DESHMUKH GAURI NITEEN MRW403P 20 228 MP Pharmaceutics OTHER (KINDLY SPECIFY)FORMULATION, DEVELOPMENT AND EVALUATION OF SOLID ORAL
DOSAGE FORM OF PAROXETINE HYDROCHLORIDEDR. PRAFUL BHARADIA
156 25-April-2019 172280820008 ROMANSHA ANIL BERI MRW403P 20 228 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION, DEVELOPMENT AND EVALUATION OF SUBLINGUAL
TABLETS OF AN ANTI-PSYCHOTIC DRUGDR. YAMINI SHAH
157 25-April-2019 172280820010 SOLANKI SNEHABEN BALDEVBHAI MRW403P 20 228 MP Pharmaceutics OTHER (KINDLY SPECIFY)PAEDIATRIC FORMULATION OF CEFIXIME TRIHYDRATE AND ITS
EVALUATIONDR. YAMINI SHAH
158 02-May-2019 172280825002 DOBARIYA KOMAL MRW403P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE
SPECIFY DISORDER)
EVALUATE THE THERAPEUTIC POTENTIAL OF CHRYSIN IN TYPE -2
DIABETES AND ITS COMPLICATIONSDR. ANITA A MEHTA
159 02-May-2019 172280825003 GORAKHIYA MONIKA SHAILESHBHAI MRW403P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE
SPECIFY DISORDER)
ASSESSMENT OF INSULIN EFFECT IN HYPOTHYROIDISM AND
OBESITY IN RATS
DR. MUSTAKIM M.
MANSURI
160 02-May-2019 172280825004 JAINEEL RAJESHBHAI DHAROD MRW403P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE
SPECIFY DISORDER)
EVALUATION OF ANTI-OBESITY EFFECT OF BUPROPION AND L-
HISTIDINE COMBINATION IN HFD INDUCED OBESITY IN MICEDR. GAURANG B. SHAH
161 02-May-2019 172280825009 YADAV RUCHIBEN SHITALAPRASAD MRW403P 25 228 MP PharmacologyMETABOLIC DISORDER ( PLEASE
SPECIFY DISORDER)
EFFECT OF GENISTEIN ON OVARIAN FUNCTION IN
HYPOTHYRODISED RAT
DR. MUSTAKIM M.
MANSURI
162 25-April-2019 172280824004 MODI PINAL SATISHKUMAR MRW403P 24 228 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF NEBIVOLOL HYDROCHLORIDE AND
TELMISARTAN IN THEIR COMBINED DOSAGE FORM
DR. SINDHU EZHAVA
163 02-May-2019 172280825006 PURAV SUNILBHAI PATEL MRW403P 25 228 MP Pharmacology CVS DISORDEREVALUATE THE EFFECT OF TLR-4 ANTAGONIST IN EXPERIMENTAL
MODEL OF MYOCARDIAL INFARCTIONDR. ANITA A MEHTA
164 25-April-2019 172280824005 Patel Nidhi Tikendrabhai MRW403P 24 228 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF CHROMATOGRAPHIC
METHOD FOR SIMULTANEOUS ESTIMATION OF OFLOXACIN,
TINIDAZOLE, TERBINAFINE HYDROCHLORIDE AND CLOBETASOL
PROPIONATE IN TOPICAL FORMULATION
DR. KUNJAN BODIWALA
165 25-April-2019 172280824008 SHARMA PRIYANKA KAMLESHBHAI MRW403P 24 228 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF A STABILITY INDICATING
HPTLC METHOD FOR TENELIGLIPTIN AND METFORMIN.DR. MAHESH T. CHHABRIA
166 02-May-2019 172280825001 BHOOMIT MAHENDRABHAI PATEL MRW403P 25 228 MP Pharmacology CANCEREFFECT OF DISULFIRAM AND CAFFEINE ON NSCLC RESISTANCE TO
GEMCITABINE AND CISPLATINDR. SUNITA GOSWAMI
167 02-May-2019 172280825007 Sangtani Kajol Haresh MRW403P 25 228 MP Pharmacology CNS DISORDER
ASSESSMENT OF THE RELATIONSHIP BETWEEN ANTIDEPRESSANT
AND COGNITION IMPROVING ABILITIES OF SHANKHPUSHPI AND
ASHWAGANDHA EXTRACTS IN MICE
DR. SUNITA GOSWAMI
168 02-May-2019 172280825008 Suthar Hiran Nilesh MRW403P 25 228 MP Pharmacology CNS DISORDER
EVALUATION OF WITHANIA SOMNIFERA AND CONVULVULUS
PLURICAULIS (CHOISY) ON VARIOUS DOMAINS OF COGNITION
IMPAIRED IN SUB-CHRONIC KETAMINE INDUCED SCHIZOPHRENIA
IN RATS
DR. GAURANG B. SHAH
169 26-April-2019 172280824003 HAPPY PARIN PATEL MRW403P 24 228 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING
CHROMATOGRAPHIC METHOD FOR ESTIMATION OF ALFUZOSIN
HYDROCHLORIDE AND SOLIFENACIN SUCCINATE IN THEIR
COMBINED DOSAGE FORM
DR. SINDHU EZHAVA
170 26-April-2019 172280824006 Shah Jaldhi Hemantbhai MRW403P 24 228 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING
METHOD FOR ESTIMATION OF DAPAGLIFLOZIN AND ITS
APPLICATION TO STUDY DEGRADATION KINETICS
DR. KUNJAN BODIWALA
171 30-April-2019 172310820001 Balas Mayur Vashrambhai MRW403P 20 231 MP PharmaceuticsNANO SUSPENSION/EMULSION,
SEDDS, LIPID BASED DDS
FORMULATION AND EVALUATION OF NIOSOMAL GEL OF
VORICONAZOLE FOR SEVERE FUNGAL INFECTIONDR. SANDIP PATEL
172 30-April-2019 172310820002 Garachar Dhaval Ranabhai MRW403P 20 231 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND CHARACTERIZATION OF ACARBOSE OSMOTIC
TABLETSMR. SUMIT CHAKRABORTY
173 30-April-2019 172310820003 KALARIA VISHWA JITENDRABHAI MRW403P 20 231 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
DESIGN AND EVALUATION OF INSITU GEL EYE DROPS CONTAINING
NANOPARTICLES OF GEMIFLOXACIN MESYLATEMR. SUMIT CHAKRABORTY
174 29-April-2019 172350820001 Bariya Hiralbhai Ranchhodbhai MRW403P 20 235 MP Pharmaceutics
CO PROCESSED, DC,
TABLET/CAPSULE EXCIPIENTS AND
AT
FORMULATION DEVELOPMENT AND CHARACTERIZATION OF
DIRECTLY COMPRESSIBLE TABLETS OF NISOLDIPINE LOADED
SPHERICAL CRYSTAL AGGLOMERATES
DR. HITESH JAIN
175 29-April-2019 172350820002 Dindod Swetalben Babubhai MRW403P 20 235 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
DESIGN AND CHARACTERIZATION OF MICROSPONGE LOADED
TOPICAL GEL OF LULICONAZOLEDR. HITESH JAIN
176 29-April-2019 172350820003 NEHATE SHWETA BHAGWAN MRW403P 20 235 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
FORMULATION DEVELOPMENT AND OPTIMIZATION OF
MUCOADHESIVE IN SITU NASAL GEL CONTAINING MONTELUKAST
SODIUM
DR. HITESH JAIN
177 01-May-2019 172390820004 CHIRAG NATUBHAI PATEL MRW403P 20 239 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
DESIGN AND CHARACTERIZATION OF TRANSDERMAL PATCH OF
VENLAFAXINE HYDROCHLORIDEDR. HITESH DALVADI
178 01-May-2019 172390820009 Patel Kinjal Ishwarbhai MRW403P 20 239 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
DESIGN & OPTIMIZATION OF INTRANASAL DRUG DELIVERY(SPRAY)
OF QUETIAPINE FUMARATEDR. HITESH DALVADI
179 01-May-2019 172390820010 SIDDIKI DOLLY SAFIULREHMAN MRW403P 20 239 MP Pharmaceutics FORMULATION, EVALUATION AND OPTIMIZATION OF
MICROEMULSION BASED HYDROGEL OF TOLNAFTATEDR. HITESH DALVADI
180 01-May-2019 172390820002 BHANDARI RINAL HASMUKHRAI MRW403P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION, EVALUATION AND OPTIMIZATION OF IN-SITU
NASAL GEL OF FROVATRIPTAN SUCCINATEMR. TULARAM BAROT
181 01-May-2019 172390820005 HALPATI DARSHITA UMESH MRW403P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
DEVELOPMENT AND EVALUATION OF NANOPARTICLE BASED IN-
SITU GEL OF LOTEPREDNOL ETABONATEDR. HITESH DALVADI
182 01-May-2019 172390820012 SINGH SHOBHA DESHRAJ MRW403P 20 239 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND DEVELOPMENT OF IN-SITU GEL FOR OCULAR
DRUG DELIVERY OF TRAVOPROSTDR. KOMAL PARMAR
183 01-May-2019 172390820001 BEHERA SHREEKANT SHIVRAM MRW403P 20 239 MP Pharmaceutics OTHER (KINDLY SPECIFY)FORMULATION AND DEVELOPMENT OF POLYMERIC MICELLE FOR
DISSOLUTION ENHANCEMENT OF EXEMESTANEDR. KOMAL PARMAR
184 01-May-2019 172390820003 CHAUHAN VRUTTIKUMARI BANKIMSINH MRW403P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,
SEDDS, LIPID BASED DDS
DEVELOPMENT, EVALUATION AND OPTIMIZATION OF
OXICONAZOLE NITRATE LOADED SOLID LIPID NANOPARTICLE
BASED GEL
MR. TULARAM BAROT
185 01-May-2019 172390820006 OZA KIRTIBAHEN MANISHKUMAR MRW403P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,
SEDDS, LIPID BASED DDS
FORMULATION, EVALUATION AND OPTIMIZATION OF
NANOSUSPENSION FOR DISSOLUTION ENHANCEMENT OF
ZOTEPINE
DR. KOMAL PARMAR
186 01-May-2019 172390820008 PATEL JIGNESHBHAI UTTAMBHAI MRW403P 20 239 MP PharmaceuticsNANO SUSPENSION/EMULSION,
SEDDS, LIPID BASED DDS
FORMULATION AND DEVELOPMENT OF NOVEL BIGEL TOPICAL
DRUG DELIVERY OF LULICONAZOLEDR. KOMAL PARMAR
187 02-May-2019 172390825001 RAJAWAT MAYANK PRAFUL MRW403P 25 239 MP PharmacologyRESPIRATORY DISORDER ( PLEASE
SPECIFY DISORDER OR
PHARMACOLOGICAL SCREENING OF FOUR PROPIETARY
POLYHERBAL FORMULATION FOR THE TREATMENT OF COUGH.MR. MITTAL DALAL
188 02-May-2019 172390825004 TANDEL SHIVANI RAJESHBHAI MRW403P 25 239 MP Pharmacology EYE DISORDEREFFECT OF ISOTINE®, ISOTINE PLUS® AND ISOTINE GOLD® IN
EXPERIMENTAL MODELS OF CATARACT AND GLAUCOMA.DR. ARINDAM PAUL
189 01-May-2019 172390824001 BHANUSHALI PRIYA DEVJIBHAI MRW403P 24 239 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
SPECTROSCOPIC AND CHROMATOGRAPHIC METHODS
DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF CILNIDIPINE
AND BISOPROLOL FUMARATE IN COMBINED DOSAGE FORM
DR. ALISHA PATEL
190 01-May-2019 172390824002 KAMLI ANKITA SHANTILAL MRW403P 24 239 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF CANDESARTAN CILEXETIL AND
AMLODIPINE BESYLATE IN SYNTHETIC MIXTURE
MADHURI HINGE
191 01-May-2019 172390824003 KUMBHAR RIDDHI SHIVAJI MRW403P 24 239 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
ANALYTICAL METHODS DEVELOPMENT AND VALIDATION FOR
AMLODIPINE BESYLATE AND CELECOXIB AND EVALUATION OF AN
ACTIVATED CARBON BASED DEACTIVATION SYSTEM FOR DISPOSAL
OF DIFFERENT MEDICATIONS
DR. ALISHA PATEL
192 02-May-2019 172390825003 SHAIKH UMAIRA ABDULRAKIB MRW403P 25 239 MP Pharmacology OTHER (KINDLY SPECIFY)ANTICOAGULANT AND ANTIHEMOLYTIC ACTIVITY OF TECOMELLA
UNDULATA -AN EXPERIMENTAL STUDYDR. ANKIT H MERAI
193 01-May-2019 172390824005 PATEL HETA AMRUTBHAI MRW403P 24 239 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
SIMULTANEOUS ESTIMATION OF AMITRIPTYLINE HYDROCHLORIDE
AND PERPHENAZINE IN SYNTHETIC MIXTURE
MRS. MEGHA ASHESH
SHAH
194 01-May-2019 172390824004 Madhumita Ghosh Chowdhury MRW403P 24 239 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
ESTIMATION OF LIFITEGRAST IN ITS PHARMACEUTICAL DOSAGE
FORM
MADHURI HINGE
195 25-April-2019 172420820002 Parekh Aarti Jayprakash MRW403P 20 242 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
DEVELOPMENT & EVALUATION OF GASTRO RETENTIVE FLOATING
TABLETS FOR ORAL DRUG DELIVERY OF ENTACOPONEDR DHAVAL J PATEL
196 25-April-2019 172420820004 Patel Parth Laxmanbhai MRW403P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION AND EVALUATION OF GASTRIC FLOATING TABLETS
CONTAINING CAPTOPRIL AND HYDROCHLOROTHIAZIDEDR S.K.SHAH
197 25-April-2019 172420820005 PATEL PRIYANK MUKESHBHAI MRW403P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION AND IN-VITRO DISSOLUTION ENHANCEMENT OF
BLONANSERIN USING LIQUISOLID COMPACTSDR SANJESH G RATHI
198 25-April-2019 172420820007 SHAH JIGAR PRADIPKUMAR MRW403P 20 242 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION DEVELOPMENT AND EVALUATION OF FLOATING
TABLETS OF APREMILASTDR DHAVAL J.PATEL
199 25-April-2019 172420820001 GOSWAMI ASAV NARENDRAPURI MRW403P 20 242 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
PHYSICOCHEMICAL CHARACTERIZATION AND IN-VITRO
DISSOLUTION ENHANCEMENT OF RANOLAZINE USING SOLID
DISPERSION METHOD
DR S.K.SHAH
200 25-April-2019 172420824003 MANGROLIYA RUCHITA HIMMATBHAI MRW403P 24 242 MPPharmaceutical
Quality AssurancePROCESS VALIDATION
PROSPECTIVE PROCESS VALIDATION OF ANTIINFLAMMATORY
(CORTICOSTEROID) INJECTION SUSPENSION USP 40 MG/MLDR. ANKIT B. CHAUDHARY
201 25-April-2019 172420824005 SUDHIRKUMAR GAMI MRW403P 24 242 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR
SIMULTANEOUS ESTIMATION OF BENIDIPINE HYDROCHLORIDE,
TELMISARTAN AND CHLORTHALIDONE IN TABLET
DR. ANKIT B. CHAUDHARY
202 25-April-2019 172420824006 SUTHAR NISHABEN JAYESHKUMAR MRW403P 24 242 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND
VALIDATION FOR SIMULTANEOUS ESTIMATION OF ORLISTAT AND
RESVERATROL IN CAPSULE
MS. CHARMY D. PANDYA
203 26-April-2019 172420824001 BAGHEL LAXMI SHIVNARAYANSINGH MRW403P 24 242 MPPharmaceutical
Quality AssuranceREGULATORY AFFAIRS
DOCUMENTATION IN QUALITY MANAGEMENT SYSTEM (QMS) AND
DATA INTEGRITY IN PHARMACEUTICAL INDUSTRYMS. JIGNA T. PATEL
204 26-April-2019 172420824004 PATEL MINALBEN VINODBHAI MRW403P 24 242 MPPharmaceutical
Quality AssuranceREGULATORY AFFAIRS
A COMPREHENSIVE AND COMPARATIVE STUDY ON REGULATIONS
OF MEDICAL COUNTERMEASURES IN USA, EUROPE AND INDIADR. ANKIT B. CHAUDHARY
205 29-April-2019 172440820003 PATEL RIKIN RAMESH MRW403P 20 244 MP Pharmaceutics OTHER (KINDLY SPECIFY)FORMULATION, DEVELOPMENT AND EVALUATION OF MEDICATED
CHEWING GUM OF AVANAFILM. RAHIL G. BHURA
206 02-May-2019 172450829001 Chaudhary Rajat b MRW403P 29 245 MP Clinical Pharmacy BABE STUDY
A RANDOMIZED DOUBLE BLINDED, CROSS-OVER BIOEQUIVALENCE
STUDY OF FELODIPINE EXTENDED RELEASE (10 MG) TABLET UNDER
FASTING CONDITION
DR. I. S. ANAND
207 02-May-2019 172450829002 Chaudhary Shefali Jayantibhai MRW403P 29 245 MP Clinical Pharmacy OTHER (KINDLY SPECIFY)STUDY ON PRESCRIBING PATTERN OF ANTIBIOTICS IN PATIENTS
ADMITTED TO INTENSIVE CARE UNITSDR. I. S. ANAND
208 02-May-2019 172450829003 Chaudhary Sumanben Rameshbhai MRW403P 29 245 MP Clinical Pharmacy BABE STUDY
A RANDOMIZED CROSS-OVER BIOEQUIVALENCE STUDY OF
METOPROLOL SUCCINATE EXTENDED RELEASE (200 MG) TABLET
UNDER FASTING CONDITION
DR. I. S. ANAND
209 26-April-2019 172450820001 Chaudhary Jigneshkumar Ishwarbhai MRW403P 20 245 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION AND OPTIMIZATION OF ORODISPERSIBLE TABLET
OF A SELECTIVE ALPHA ADRENERGIC BLOCKING AGENT USING
NEFTOPIDIL
DR. H.D.KAREN
210 26-April-2019 172450820002 Vaghela Harshkumar Chamanlal MRW403P 20 245 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
PREPARATION AND EVALUATION OF SUSTAINED RELEASE TABLET
OF NIFEDIPINEDR. P. H. PRAJAPATI
211 26-April-2019 172450824001 PATEL RITUBEN JASHVANTBHAI MRW403P 24 245 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY STUDY OF SULTAMICILLIN AND ITS TABLET
FORMULATION UNDER ACCELERATED AND STRESS CONDITIONDR. J. B. DAVE
212 29-April-2019 172460824004 PRACHI GUPTA MRW403P 24 246 MPPharmaceutical
Quality AssuranceQUALITY RISK MANAGEMENT
A SYSTEMATIC APPROACH TO NEW PRODUCT INTRODUCTION
WITH EMPHASIS ON THE CONTAINMENT STRATEGIES AND
QUALITY RISK MANAGEMENT
DR ANKITA BHAVSAR
213 29-April-2019 172460824002 DESAI PAMIL SHAMJIBHAI MRW403P 24 246 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING
METHOD FOR ESTIMATION OF RIOCIGUAT IN BULK AND
PHARMACEUTICAL DOSAGE FORM
DR ANKITA BHAVSAR
214 26-April-2019 172470820009 PANDIT VIPULKUMAR DINESHKUMAR MRW403P 20 247 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
FORMULATION AND EVALUATION OF BUCCAL FILMS OF
SAXAGLIPTINMR. VIJAY K. PATEL
215 26-April-2019 172470820002 GAJERA KAUSHIKBHAI GHANSHYAMBHAI MRW403P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLETS OF
PALIPERIDONEMR. ANIL G. RAVAL
216 26-April-2019 172470820003 JOSHI ARJUN LALITBHAI MRW403P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION AND EVALUATION OF SUBLINGUAL FILMS OF
APIXABANDR. YOGESH K. PATEL
217 26-April-2019 172470820007 MEHTA HIR RAJIV KUMAR MRW403P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION DEVELOPMENT AND EVALUATION OF
GASTRORETENTIVE FLOATING FILMS OF LAFUTIDINEMR. VIJAY K. PATEL
218 26-April-2019 172470820012 SHAH AKASHKUMAR NARESHKUMAR MRW403P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND EVALUATION OF COLON TARGETED PELLETS
OF BUMADIZONE CALCIUMMR. ANIL G. RAVAL
219 26-April-2019 172470820001 AGRAWAL HIMANSHU GOPALBHAI MRW403P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
PHYSICOCHEMICAL CHARACTERISATION AND IN VITRO
DISSOLUTION ENHANCEMENT OF AGOMELATINE USING SOLID
DISPERSION METHOD
MR. VIJAY K. PATEL
220 26-April-2019 172470820011 PRAJAPATI KAJALBEN ARVINDBHAI MRW403P 20 247 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION AND EVALUATION OF ORALLY DISINTEGRATING
TABLETS OF MIRABEGRONDR. DHARA B. PATEL
221 26-April-2019 172470820013 SHARMA SUNNY SURESHBHAI MRW403P 20 247 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND EVALUATION OF CONTROLLED RELEASE
OSMOTIC TABLET OF CARVEDILOL PHOSPHATEMR. ANIL G. RAVAL
222 26-April-2019 172470824001 ANSARI AFSHANNIKHAT AQEELAHMED MRW403P 24 247 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-
HPLC METHOD FOR ESTIMATION OF SERTACONAZOLE NITRATE
AND BECLOMETHASONE DIPROPIONATE IN CREAM
MS. ANKITA S. PATEL
223 26-April-2019 172470824002 DHARU NEETUKUMARI RAJESHBHAI MRW403P 24 247 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-
HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF
NADIFLOXACIN AND CLOBETASOL PROPIONATE IN CREAM
MS. KUNJAL L. VEGAD
224 26-April-2019 172470824003 HARDIK KIRTIKUMAR BHAVSAR MRW403P 24 247 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ASSAY
METHOD FOR ESTIMATION OF TAMSULOSIN HYDROCHLORIDE AND
TOLTERODINE TARTRATE IN CAPSULES
DR. VINAY C. DARJI
225 26-April-2019 172470824008 PATEL RINKAL MUKESHBHAI MRW403P 24 247 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND
VALIDATION FOR SIMULTANEOUS ESTIMATION OF OXYCODONE
HCL AND NALTREXONE HCL IN CAPSULE
MR. KAUSHIK R. PATEL
226 26-April-2019 172470824011 PATIL POOJA SATISHBHAI MRW403P 24 247 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-
HPLC METHOD FOR ESTIMATION OF MICONAZOLE NITRATE AND
HYDROCORTISONE IN CREAM
DR. VINAY C. DARJI
227 26-April-2019 172470824012 Rathod Jinal Harshadkumar MRW403P 24 247 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-
HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF
CLOTRIMAZOLE, CLINDAMYCIN PHOSPHATE AND TINIDAZOLE
CAPSULE
MR. JAYMIN G. PATEL
228 26-April-2019 172470824004 MEGHA JINAL MUKESHBHAI MRW403P 24 247 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF
BENIDIPINE HCL, TELMISARTAN AND CHLORTHALIDONE IN TABLET
MS. ANKITA S. PATEL
229 26-April-2019 172470824006 PATEL DHARABEN BHARATKUMAR MRW403P 24 247 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF
PARACETAMOL AND ZALTOPROFEN IN TABLET
MR. KAUSHIK R. PATEL
230 26-April-2019 172470824007 PATEL POOJABEN AJAYBHAI MRW403P 24 247 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF
BRINZOLAMIDE AND BRIMONIDINE TARTRATE IN OPHTHALMIC
SUSPENSION
DR. VINAY C. DARJI
231 26-April-2019 172470824009 PATEL SEEMA NITINBHAI MRW403P 24 247 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF
AMLODIPINE BESYLATE AND CELECOXIB IN SYNTHETIC MIXTURE
MS. BHUMI R. PATEL
232 26-April-2019 172470824010 PATEL UPASANA KANTILAL MRW403P 24 247 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF
STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF
MEROPENEM AND VABORBACTAM IN SYNTHETIC MIXTURE
MR. JAYMIN G. PATEL
233 26-April-2019 172470824015 VYAS KAJAL SHAILESHKUMAR MRW403P 24 247 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-
HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF FLUTICASONE
FUROATE AND VILANTEROL TRIFENATATE IN INHALATION POWDER
MS. ANKITA S. PATEL
234 26-April-2019 172470824013 Salunkhe Suchitra Sunil MRW403P 24 247 MPPharmaceutical
Quality AssurancePROCESS VALIDATION
PROCESS VALIDATION OF RIFAMPICIN AND ISONIAZID FILM
COATED TABLETSMR.JAYMIN G. PATEL
235 26-April-2019 172470824014 VAGH VIRAL VITTHALBHAI MRW403P 24 247 MPPharmaceutical
Quality AssurancePROCESS VALIDATION
PROCESS OPTIMIZATION AND PROCESS VALIDATION OF
MYOINOSITOL AND D-CHIRO INOSITOL FILM COATED TABLET MS. BHUMI R. PATEL
236 26-April-2019 162470804013 patel nikita mahendrabhai 940104 04 247 MPQUALITY
ASSURANCE
STABILITY INDICATING RP-HPLC METHOD METHOD DEVELOPMENT
AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF
TICLOPIDINE AND ASPIRIN IN ITS PHARMACEUTICAL DOSAGE FORM
Mr.Jaymin G.Patel
237 26-April-2019 172520820001 BULA SANA MOHAMMADHUSAIN MRW403P 20 252 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
DEVELOPMENT AND CHARACTERIZATION OF FLOATING-
MUCOADHESIVE TABLET CONTAINING QUETIAPINE FUMARATEDR ALPESH D PATEL
238 01-May-2019 172540820002 Gangat Asma Abdulsattar MRW403P 20 254 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
FABRICATION AND CHARACTERIZATION OF LULICONAZOLE FILM-
FORMING TOPICAL SPRAY FOR THE TREATMENT OF FUNGAL
INFECTION
DR. BHAVESH AKBARI
239 01-May-2019 172540820001 CHAUHAN RISHABH HEMANTKUMAR MRW403P 20 254 MP PharmaceuticsNANO SUSPENSION/EMULSION,
SEDDS, LIPID BASED DDS
DEVELOPMENT AND EVALUATION OF GELATIN TREATED
ACECLOFENAC LOADED EUDRAGIT RS 100 NANOSUSPENSION FOR
OSTEOARTHRITIS TREATMENT
DR. MANISH GOYANI
240 01-May-2019 172540820003VARADE SNEHALKUMARI
MADHUKARBHAIMRW403P 20 254 MP Pharmaceutics OTHER (KINDLY SPECIFY)
PREPARATION AND CHARACTERIZATION OF SPHERICAL
AGGLOMERATES OF LORATADINE TO IMPROVE DISSOLUTION RATE
AND MICROMERITIC PROPERTIES
DR. BHAVESH AKBARI
241 01-May-2019 172540824001 ANCY MATHEW MRW403P 24 254 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
ANALYTICAL METHODS DEVELOPMENT AND VALIDATION FOR THE
ESTIMATION OF VORTIOXETINE AND ARIPIPRAZOLE IN SYNTHETIC
MIXTURE
DR. SURESH KUMAR
242 01-May-2019 172540824002 Jangra Sandeepkumar Parasram MRW403P 24 254 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
THE ESTIMATION OF MIRABEGRON AND SOLIFENACIN SUCCINATE
IN SYNTHETIC MIXTURE
DR. SURESH KUMAR
243 01-May-2019 172540824003 MAHIDA KAJAL RAKESHKUMAR MRW403P 24 254 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
THE ESTIMATION OF DOXOFYLLINE AND ERDOSTEINE IN SYNTHETIC
MIXTURE
DR. SURESH KUMAR
244 01-May-2019 172540824005 PATEL HINAL HARISHBHAI MRW403P 24 254 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF
SIMULTANEOUS ESTIMATION OF PREGABALIN AND MELOXICAM IN
BINARY MIXTURE
MR. ROHAN BARSE
245 01-May-2019 172540824006 VARACHHIYA HIRAL JASVANTSINH MRW403P 24 254 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
THE ESTIMATION OF ITOPRIDE HYDROCHLORIDE AND
OMEPRAZOLE IN SYNTHETIC MIXTURE
MR. ROHAN BARSE
246 02-May-2019 172540825001 CHAUHAN VATSALSINH RAJENDRASINH MRW403P 25 254 MP Pharmacology CNS DISORDERpharmacological evaluation of Operculina turpethum root extract in
scopolamine-induced cognitive impairments in rats.DR. PALLAVI K.J
247 02-May-2019 172540825003 PARMAR JANHAVI ANILKUMAR MRW403P 25 254 MP Pharmacology CNS DISORDERpharmacological evaluation of Anti-inflammatory & Anti-
nociceptive activities of Doronicum hookeri root extract in ratsDR. PALLAVI K.J
248 02-May-2019 172540825004 SHAIKH ZEBABIBI ZAHIR MRW403P 25 254 MP Pharmacology CNS DISORDERpharmacological evaluation of Antidepressant activity of Vigna
radiata seed extract in rats.DR. PALLAVI K.J
249 01-May-2019 172540824004 Mandloi Nikita Rampalsingh MRW403P 24 254 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
ANALYTICAL METHODS DEVELOPMENT AND ITS VALIDATION FOR
THE ESTIMATION OF TENELIGLIPTIN HYDROBROMIDE HYDRATE
AND GLIMEPIRIDE IN SYNTHETIC MIXTURE
DR. SURESH KUMAR
250 30-April-2019 172540822004 PATEL SAMEERA SULEMAN MRW403P 22 254 MPPharmaceutical
ChemistryMEDICINAL CHEMISTRY
SYNTHESIS AND EVALUATION OF NEW 7-HYDROXY COUMARIN
DERIVATIVES AS ANTI- ALZHEIMER AGENTSDR. MORE UTTAM
251 30-April-2019 172540822001 DHARASANDIYA ARZOO PRABHUDAS MRW403P 22 254 MPPharmaceutical
Chemistry
MEDICINAL CHEMISTRY
(ANTICANCER)
SYNTHESIS OF NEW BRIDGEHEAD NITROGEN HETEROCYCLES AS
POTENTIAL ANTICANCER AGENTSDR. M. N. NOOLVI
252 30-April-2019 172540822002 JOSHI NIDHIBEN BHASKARBHAI MRW403P 22 254 MPPharmaceutical
Chemistry
MEDICINAL CHEMISTRY
(ANTICANCER)
SYNTHESIS OF NEW QUINAZOLINE DERIVATIVES AS ANTICANCER
AGENTSMS. MONIKA KAKADIYA
253 30-April-2019 172540822003 MOGAL AZMIN MAHERVAN MRW403P 22 254 MPPharmaceutical
Chemistry
MEDICINAL CHEMISTRY
(ANTICANCER)
SYNTHESIS OF NEW TAMOXIFEN ANALOGUES AS POTENTIAL
ANTICANCER AGENTSDR. M. N. NOOLVI
254 30-April-2019 172540822005 PATEL ZOFINA IKBAL MRW403P 22 254 MPPharmaceutical
Chemistry
MEDICINAL CHEMISTRY
(ANTICANCER)
SYNTHESIS OF NEW CANTHARIDIN DERIVATIVES AS POTENTIAL
ANTICANCER AGENTSDR. M. N. NOOLVI
255 30-April-2019 172540822007 Rahevar Vidhikumari Bhupeshkumar MRW403P 22 254 MPPharmaceutical
ChemistryMEDICINAL CHEMISTRY
SYNTHESIS AND EVALUATION OF NEW FLAVONOID DERIVATIVES AS
ANTI-ALZHEIMER AGENTSDR. MORE UTTAM
256 30-April-2019 172540822008 SINGH RAMIYA TILAKDHARI MRW403P 22 254 MPPharmaceutical
ChemistryMEDICINAL CHEMISTRY
SYNTHESIS OF NEW QUINOLINE DERIVATIVES AS ANTITUBERCULAR
AGENTSMS. MONIKA KAKADIYA
257 30-April-2019 172540822009 Zalavadiya Vivek Sureshbhai MRW403P 22 254 MPPharmaceutical
Chemistry
MEDICINAL CHEMISTRY
(ANTICANCER)
SYNTHESIS OF NEW CHROMAN-4-ONE DERIVATIVES AS POTENTIAL
ANTICANCER AGENTSDR. M. N. NOOLVI
258 25-April-2019 172600820001 ANKIT SINGH KUSHWAH MRW403P 20 260 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
DEVELOPMENT, OPTIMIZATION AND EVALUATION OF EXTENDED
RELEASE TABLET OF PALIPERIDONEDR. KUNAL N. PATEL
259 25-April-2019 172600820004 PATEL KRUSHIKA JAGDISHKUMAR MRW403P 20 260 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION AND EVALUATION OF MOUTH DISSOLVING FILM OF
FEXOFENADINE HYDROCHLORIDEDR. KUNAL N. PATEL
260 26-April-2019 172600824005 PATEL AISHWARYA JITENDRA MRW403P 24 260 MPPharmaceutical
Quality AssuranceDISSOLUTION STUDIES
DEVELOPMENT AND VALIDATION OF DISSOLUTION TEST METHOD
FOR FLUNARIZINE, DOMPERIDONE AND PARACETAMOL IN
PHARMACEUTICAL DOSAGE FORM
DR. CHIRAG J. PATEL
261 25-April-2019 172600824001 BAMBHROLIYA VIREN GHANSHYAMBHAI MRW403P 24 260 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
ESTIMATION OF FLUTICASONE IN HUMAN PLASMA BY LC-MS/MSDR. CHIRAG J. PATEL
262 25-April-2019 172600824004 PANCHAL SHIVANI HITESHKUMAR MRW403P 24 260 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ASSAY
METHOD FOR ESTIMATION OF TOFACITINIB IN TOFACITINIB
CITRATE IMMEDIATE RELEASE TABLET DOSAGE FORM
DR. CHIRAG J. PATEL
263 25-April-2019 172600824006 PATEL DIMPLE NATVARLAL MRW403P 24 260 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
METHOD DEVELOPMENT AND VALIDATION BY
CHROMATOGRAPHIC METHOD FOR DETERMINATION OF
ERYTHROMYCIN IN PHARMACEUTICAL DOSAGE FORM
DR. CHIRAG J. PATEL
264 26-April-2019 172600824007 THAKKER KRINA SURESHKUMAR MRW403P 24 260 MPPharmaceutical
Quality AssurancePROCESS VALIDATION
PROCESS VALIDATION OF OPTIMIZED FORMULATION OF
VENLAFAXINE HYDROCHLORIDE 37.5 MG TABLET DOSAGE FORM DR. CHIRAG J. PATEL
265 25-April-2019 172620820002 PARMAR MADHAVSINH VIJAYBHAI MRW403P 20 262 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND CHARACTERIZATION OF MOUTH DISSOLVING
TABLETS OF VILAZODONE HCL PROF. RAVI V. PATEL
266 25-April-2019 172620820004 PRAJAPATI RINKUBEN ASHOKBHAI MRW403P 20 262 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND OPTIMIZATION OF SUSTAINED RELEASE DRUG
DELIVERY SYSTEM OF SOFOSBUVIR PROF. BHUMI RAVAL
267 25-April-2019 172620820005 SHAH AMIBEN MAHESHKUMAR MRW403P 20 262 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION AND CHARACTERIZATION OF FAST DISSOLVING
TABLETS OF LINAGLIPTIN- AN ANTI-DIABETIC AGENTPROF. SURAJ R. CHAUHAN
268 25-April-2019 172620820006 SHUKLA ABHAYKUMAR SANTOSH MRW403P 20 262 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION AND OPTIMIZATION OF ORAL DISINTEGRATING
STRIPS OF TENELIGLIPTIN FOR THE TREATMENT OF TYPE II
DIABETES
PROF. RAVI V. PATEL
269 25-April-2019 172620820001 BACHANI KOMAL KANAIYALAL MRW403P 20 262 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF
ADEFOVIR DIPIVOXIL FOR THE TREATMENT OF HEPATITIS BPROF. BHUMI RAVAL
270 25-April-2019 172620824001 BASITA NIKHIL CHAMPAKBHAI MRW403P 24 262 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
ANALYTICAL METHODS DEVELOPMENT AND VALIDATION FOR
SIMULTANEOUS ESTIMATION OF PIOGLITAZONE HYDROCHLORIDE
AND VILDAGLIPTIN IN SYNTHETIC MIXTURE
DR. JITENDRA O.
BHANGALE
271 25-April-2019 172620824002 DAVE MANSIBEN SHIRISHKUMAR MRW403P 24 262 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
ANALYTICAL METHODS DEVELOPMENT AND VALIDATION FOR
SIMULTANEOUS ESTIMATION OF LOSARTAN POTASSIUM AND
ROSUVASTATIN CALCIUM IN SYNTHETIC MIXTURE
DR. JITENDRA O.
BHANGALE
272 25-April-2019 172620824009 PATEL HIRAL ASHOKBHAI MRW403P 24 262 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
ANALYTICAL METHODS DEVELOPMENT AND VALIDATION FOR
SIMULTANEOUS ESTIMATION OF RAMIPRIL AND SIMVASTATIN IN
SYNTHETIC MIXTURE
DR. JITENDRA O.
BHANGALE
273 25-April-2019 172620824011 SONARA KAJAL HARIBHAI MRW403P 24 262 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
ANALYTICAL METHODS DEVELOPMENT AND VALIDATION FOR
SIMULTANEOUS ESTIMATION OF REPAGLINIDE AND SITAGLIPTIN
PHOSPHATE IN SYNTHETIC MIXTURE
DR. JITENDRA O.
BHANGALE
274 25-April-2019 172620824003 HIMANI RAJESHKUMAR SAVANI MRW403P 24 262 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
SIMULTANEOUS ESTIMATION OF SIMVASTATIN AND PIOGLITAZONE
HYDROCHLORIDE IN SYNTHETIC MIXTURE
DR. JITENDRA O.
BHANGALE
275 25-April-2019 172620824004 MOURYA POONAM GHANSHYAMBHAI MRW403P 24 262 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
SIMULTANEOUS ESTIMATION OF LISINOPRIL AND LOSARTAN
POTASSIUM IN SYNTHETIC MIXTURE
DR. JITENDRA O.
BHANGALE
276 25-April-2019 172620824008 PATEL DIVYABEN VIRCHANDBHAI MRW403P 24 262 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
METHOD DEVELOPMENT AND VALIDATION OF LEVODOPA AND
BENSERAZIDE IN ORAL DISPERSIBLE TABLET BY RP-HPLC METHOD
DR JITENDRA O.
BHANGALE
277 25-April-2019 172620824010 Saini Ravi bhanwarlal MRW403P 24 262 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
SIMULTANEOUS ESTIMATION OF VILDAGLIPTIN AND NATEGLINIDE
IN SYNTHETIC MIXTURE
DR JITENDRA O.
BHANGALE
278 25-April-2019 172620824012 TRIVEDI FORAM DHARMENDRABHAI MRW403P 24 262 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
SIMULTANEOUS ESTIMATION OF NEBIVOLOL HYDROCHLORIDE AND
LISINOPRIL IN SYNTHETIC MIXTURE
DR. JITENDRA O.
BHANGALE
279 25-April-2019 172620824006 PATEL BINAL NARESHBHAI MRW403P 24 262 MPPharmaceutical
Quality AssuranceIMPURITY PROFILING
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
IMPURITY PROFILE OF CITICOLINE SODIUM IN TABLET DOSAGE
FORM
DR. JITENDRA O.
BHANGALE
280 30-April-2019 172630824001 PATEL SAPANA JOITARAM MRW403P 24 263 MPPharmaceutical
Quality AssuranceQUALITY RISK MANAGEMENT
RP-HPLC METHOD FOR DETERMINATION OF ADAPALENE USING
CENTRAL COMPOSITE DESIGN DR. PARULA PATEL
281 30-April-2019 172640820003 GADHVI SIDDHI SANJAYDAN MRW403P 20 264 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION AND EVALUATION OF ORO DISPERSIBLE TABLETS OF
ONDANSETRON HYDROCHLORIDE
MS. DHARMISHTHA A.
MOVALIA
282 01-May-2019 172650820001 BARIA ROHANKUMAR PANKAJKUMAR MRW403P 20 265 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
FORMULATION DEVELOPMENT AND EVALUATION OF MATRIX
TABLETS OF DARIFENACIN HYDROBROMIDEMRS.ANKITA J.PATEL
283 01-May-2019 172650820005 KANZARIA JALPA HASMUKHBHAI MRW403P 20 265 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
FORMULATION DEVELOPMENT AND EVALUATION OF NASAL IN
SITU GEL OF ANTIEPILEPTIC DRUGDR. ANURADHA PRAJAPATI
284 01-May-2019 172650820008 PATEL MANSVIBEN SURESHBHAI MRW403P 20 265 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED
RELEASE DRUG DELIVERY SYSTEM OF LUBIPROSTONEMR. AJAY TALELE
285 01-May-2019 172650820007 PATEL ARMY PRAKASHBHAI MRW403P 20 265 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION DEVELOPMENT AND EVALUATION OF SUBLINGUAL
TABLET CONTAINING NISOLDIPINEDR.ANURADHA PRAJAPATI
286 01-May-2019 172650820003 HALPATI HEMANGINIBEN AMRUTBHAI MRW403P 20 265 MP PharmaceuticsNANO SUSPENSION/EMULSION,
SEDDS, LIPID BASED DDS
FORMULATION AND EVALUATION OF AZELAIC ACID EMULGEL FOR
ACNE & HYPERPIGMENTATION TREATMENTMRS.ANKITA JAY PATEL
287 01-May-2019 172650824001 BHADRA RINKALBEN MAHESHBHAI MRW403P 24 265 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
ESTIMATION OF PRIMIDONE IN K3EDTA HUMAN PLASMA BY
USING LC-ESI-MS/MS
DR.SHAILESH LUHAR
288 01-May-2019 172650824003 KHETIYA MEGHA MANOJBHAI MRW403P 24 265 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
ESTIMATION OF PAROXETINE HYDROCHLORIDE IN K3EDTA
HUMAN PLASMA BY USING LC-ESI-MS/MS
DR. SACHIN BHASKAR
NARKHEDE
289 01-May-2019 172650824006 PRAJAPATI HIRAL ARVINDBHAI MRW403P 24 265 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
ESTIMATION OF ATAZANAVIR IN K3EDTA HUMAN PLASMA BY
USING LC-ESI-MS/MS
DR. CHIRAG DESAI
290 01-May-2019 172650824007 RATHOD SHEETAL JAGDISHCHANDRA MRW403P 24 265 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
ESTIMATION OF NINTEDANIB IN K3EDTA HUMAN PLASMA BY
USING LC-APCI-MS/MS
DR.SHAILESH LUHAR
291 01-May-2019 172650824002 DHUMAL SHRADDHA SURESH MRW403P 24 265 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR
SIMULTANEOUS ESTIMATION OF OFLOXACIN, CLOTRIMAZOLE AND
ORNIDAZOLE IN THEIR COMBINED DOSAGE FORM
DR. DULENDRA P. DAMAHE
292 01-May-2019 172650824008 SINGH NEHA PRAMOD MRW403P 24 265 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
SIMULTANEOUS ESTIMATION OF OFLOXACIN, ORNIDAZOLE AND
RACECADOTRIL IN PHARMACEUTICAL DOSAGE FORM BY HPTLC
DR. DULENDRA P. DAMAHE
293 02-May-2019 172680825003 PATEL PINESHKUMAR SURESHBHAI MRW403P 25 268 MP PharmacologyRESPIRATORY DISORDER ( PLEASE
SPECIFY DISORDER OR
EVALUATION OF ANTIASTHAMATIC ACTIVITY OF ETHANOLIC
EXTRACT OF LUFFA ECHINATA ROXB. FRUITSMR. VIPUL GAJERA
294 02-May-2019 172680825002 PARMAR POOJA SURESHCHANDRA MRW403P 25 268 MP Pharmacology OTHER (KINDLY SPECIFY)
EVALUATION OF ANTI-ARTHRITIC ACTIVITY OF BLUMEA
BALSAMIFERA (L.) DC. IN EXPERIMENTALLY INDUCED ARTHRITIS IN
RATS.
MR. VIPUL GAJERA
295 02-May-2019 172680825001 MISTRY SHIVANGIBEN NARESHKUMAR MRW403P 25 268 MP PharmacologyMETABOLIC DISORDER ( PLEASE
SPECIFY DISORDER)
EVALUATION OF ANTIDIABETIC POTENTIAL OF LUFFA ECHINATA
ROXB. IN WISTAR RATSDR. VIJAY LAMBOLE
296 01-May-2019 172680824001 PARMAR VIRANCHI JITENDRASINH MRW403P 24 268 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-
HPLC METHOD FOR ESTIMATION OF VORTIOXETINE
HYDROBROMIDE IN PHARMACEUTICAL DOSAGE FORM.
MR. SAGARKUMAR P.
PATEL
297 02-May-2019 172680825004 PATEL SHITALBEN RAJUBHAI MRW403P 25 268 MP PharmacologyG.I. TRACT ( PLEASE SPECIFY
DISORDER OR DISEASE)
EFFECT OF COMBINED EXTRACT OF CORDIA DICHOTOMA FORST.
AND AEGLE MARMELOS CORR. IN EXPERIMENTAL MODELS OF
PEPTIC ULCER
DR. VIJAY LAMBOLE
298 30-April-2019 172690820001 Bhuva Mitalben Dineshbhai MRW403P 20 269 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
DESIGN, FORMULATION AND EVALUATION OF PRESS COATED
PULSATILE DRUG DELIVERY SYSTEM OF AZILSARTAN MEDOXOMIL
TABLET
MISS. SHEETAL
BUDDHADEV
299 30-April-2019 172690820004 Raninga Tushar Kishorbhai MRW403P 20 269 MP PharmaceuticsDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
DESIGN, DEVELOPMENT AND EVALUTION OF BILAYER TABLET OF
PIOGLITAZONE AND PHENFORMIN FOR EXTENDED RELEASE
SYSTEM
SHEETAL BUDDHADEV
300 26-April-2019 172780820005 SOLANKI ARTI NARENDRASINH MRW403P 20 278 MP PharmaceuticsBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
FORMULATION DEVELOPMENT AND EVALUATION OF BUCCAL
TABLETS OF ZOLPIDEM TARTRATEDR. KINJAL SOLANKI
301 26-April-2019 172780820001 DALBANJAN NIKITA SURESHBHAI MRW403P 20 278 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS
OF TELMISARTANDR. VIKRAM PANDYA
302 26-April-2019 172780820003 PANDIT MRUGESH SURESHBHAI MRW403P 20 278 MP PharmaceuticsIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVI
FORMULATION AND EVALUATION OF FAST DISSOLVING FILMS OF
LINAGLIPTINDR. VIKRAM PANDYA
303 26-April-2019 172780824004 PATEL HARSHITKUMAR PANKAJBHAI MRW403P 24 278 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR
THE SIMULTANEOUS ESTIMATION OF FLUCONAZOLE AND
BECLOMETHASONE DIPROPIONATE IN COMBINED
PHARMACEUTICAL DOSAGE FORM
DR RAJESH K PATEL
304 26-April-2019 172780824005 PATEL HINAL BALDEVBHAI MRW403P 24 278 MPPharmaceutical
Quality AssuranceSIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
THE SIMULTANEOUS ESTIMATION OF DEXCHLOPHENIRAMINE
MELEATE AND BETAMETHASONE IN COMBINED PHARMACEUTICAL
DOSAGE FORM
DR MITALI SHRIMANKER
305 26-April-2019 172780824006 PUJARA DISHA KIRITKUMAR MRW403P 24 278 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
THE SIMULTANEOUS ESTIMATION OF AMBROXOL HYDROCHLORIDE
AND GUAIFENESIN IN HUMAN PLASMA BY USING LC-MS/MS
DR KINJAL SOLANKI
306 26-April-2019 172780824008 THAKKAR BHOOMIBEN HASMUKHBHAI MRW403P 24 278 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
BIO ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR
THE SIMULTANEOUS ESTIMATION OF SOFOSBUVIR AND LEDIPASVIR
IN HUMAN PLASMA BY LC-ESI-MS/MS
DR RAJESH K PATEL
307 26-April-2019 172780824003 KHATRI HEMAXI DEVENDRAKUMAR MRW403P 24 278 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
ANNUAL PRODUCT QUALITY REVIEW (APQR) OF LOSARTAN
TABLETS 100 MGDR VIKRAM PANDYA
308 02-May-2019 172820829002 MONA HITESHKUMAR SUTHAR MRW403P 29 282 MP Clinical Pharmacy OTHER (KINDLY SPECIFY)
EVALUATION OF RATIONALITY OF ANTIMICROBIAL AND
ANTIDIARRHEAL FIX DOSE COMBINATION USED IN INDIAN
POPLUTION
DR. HETAL D. SOLANKI
309 02-May-2019 172820829003 PARMAR HEMAKSHIBEN RAMANBHAI MRW403P 29 282 MP Clinical Pharmacy OTHER (KINDLY SPECIFY)KNOWLEDGE AND PRACTICES OF ANTIBIOTICS SELF-MEDICATION
AMONG HEALTHCARE PROFESSIONAL STUDENTS IN GUJARATDR. HETAL D. SOLANKI
310 30-April-2019 172820824001 PATEL BIRAJKUMAR VIJAYBHAI MRW403P 24 282 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-
HPLC METHOD FOR FLUCONAZOLE AND BECLOMETHASONE IN ITS
COMBINED DOSAGE FORM
DR. M.B. SHANKAR
311 30-April-2019 172820824002 PATEL SUNNY HEMANTKUMAR MRW403P 24 282 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC
METHOD FOR SIMULTANEOUS ESTIMATION OF DOXOPHYLLINE
AND ACEBROPHYLLINE IN BULK AND COMBINED DOSAGE FORM.
DR. M.B.SHANKAR
312 25-April-2019 172860824001 kunal Bhatt MRW403P 24 286 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR
DETERMINATION OF CLOMIPRAMINE AND N-DESMETHYL
CLOMIPRAMINE FROM K3 EDTA HUMAN PLASMA USING LC-
MS/MS.
DR. MANDEV B. PATEL
313 25-April-2019 172860824002 Kuntalkumar maheshbhai prajapati MRW403P 24 286 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR
DETERMINATION OF AMBRISENTAN FROM K3 EDTA HUMAN
PLASMA USING LC-MS/MS.
DR. MANDEV B. PATEL
314 25-April-2019 172860824007 Prajapati Kinnari Dasharathbhai MRW403P 24 286 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
DEVELOPMENT AND VALIDATION OF BIOANALYTICAL MEHTHOD
FOR DETERMINATION OF DEFERASIROX FROM HUMAN PLASMA
USING LC-MS/MS.
MS. MINAKSHI DHORU
315 25-April-2019 172860824009 Shah Kajal Rajendrabhai MRW403P 24 286 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR
DETERMINATION OF EXEMESTANE FROM K3 EDTA HUMAN
PLASMA USING LC-MS/MS
MS. MINAKSHI DHORU
316 25-April-2019 172860824014 vikas pal MRW403P 24 286 MPPharmaceutical
Quality AssuranceBIOANALYTICAL
DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHODS
FOR DETERMINATION OF PROPAFENONE AND 5-
HYDROXYPROPAFENONE FROM K3 EDTA HUMAN PLASMA USING
LC-MS/MS
DR. MANDEV B. PATEL
317 26-April-2019 172860824005 Pandya Shivangi Krupeshchandra MRW403P 24 286 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
DETERMINATION OF DILTIAZEM MALEATE AND ENALAPRIL
MALEATE FROM ITS FIXED DOSE COMBINATION
DR. PINAK R. PATEL
318 26-April-2019 172860824011 Shukla Rashmi Rammilan MRW403P 24 286 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
DETERMINATION OF RIVAROXABAN AND ASPIRIN FROM SYNTHETIC
MIXTURE.
DR. PINAK R. PATEL
319 26-April-2019 172860824012 Sirsiker bhumi prashantbhai MRW403P 24 286 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
DETERMINATION OF TOBRAMYCIN AND FLUOROMETHOLONE
ACETATE FROM OPTHALMIC FORMULATION
DR. PINAK R. PATEL
320 25-April-2019 172860824003 MAKWANA HEMANGIBEN SHASHIKANT MRW403P 24 286 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-
HPLC METHOD FOR DETERMINATION OF EFONIDIPINE
HYDROCHLORIDE ETHANOLATE IN BULK AND TABLET DOSAGE
FORM.
MRS. BINNY D. MEHTA
321 25-April-2019 172860824008 sangale Hemangi Shivji MRW403P 24 286 MPPharmaceutical
Quality AssuranceSTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-
HPLC METHOD FOR DETERMINATION OF MIRABEGRON FROM ITS
PHARMACEUTICAL FORMULATION
MRS. BINNY D. MEHTA
322 26-April-2019 172860824013 Vasani Priyanka sureshbhai MRW403P 24 286 MPPharmaceutical
Quality AssuranceOTHER (KINDLY SPECIFY)
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR
DETERMINATION OF PAMABROM AND NSAIDs IN COMBINATIONDR. PINAK R. PATEL
323 29-April-2019 172880827001 Ansari Daraksha Muhammad MRW403P 27 288 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
A STUDY ON REGISTRATION PROCESS FOR MOISTURIZING CREAM
AND ANTI-ACNE CREAM IN INDIA, USA, EUROPEAN UNION
COUNTRIES, TANZANIA AND ETHIOPIA
MR. FENIL SHAH
324 29-April-2019 172880827002 BATADA NORIN BARKATBHAI MRW403P 27 288 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
COMPARISON OF REGULATORY REQUIREMENTS AS PER USFDA &
EMA FOR IMMEDIATE RELEASE AND EXTENDED RELEASE ORAL
FORMULATIONS AND COMPILATION OF MODULE 3 AND 5 AS PER
EMA
MR. NAGESH NANDA
325 29-April-2019 172880827004 GANDHI HANSAL VIJAY MRW403P 27 288 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
A STUDY ON REGISTRATION PROCESS OF GENERIC BUDESONIDE
DRY POWDER INHALER AS PER USFDA GUIDANCEDR. RAJESH PARIKH
326 29-April-2019 172880827005 GOHEL SAGAR KISHORBHAI MRW403P 27 288 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
A STUDY ON SUMMARY TECHNICAL DOCUMENTATION (STED) FOR
TRANSCATHETER SEPTAL OCCLUDER AS PER INTERNATIONAL
MEDICAL DEVICE REGULATORS FORUM (IMDRF)
DR. ANAND SHAH
327 29-April-2019 172880827006 JADAV RAHUL KIRITKUMAR MRW403P 27 288 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
A STUDY ON REGULATORY REQUIREMENTS TO PREVENT
COUNTERFEIT DRUGS IN USA, EUROPE & INDIAMR. NIRAV CHOKSHI
328 29-April-2019 172880827007 JAGANI DHARMESHKUMAR UKABHAI MRW403P 27 288 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
PREPARATION OF DRAFT ABBREVIATED NEW DRUG APPLICATION
(ANDA) FOR OSELTAMIVIR CAPSULE AS PER USFDADR. ANAD SHAH
329 29-April-2019 172880827008 PATEL PANKTIBEN KIRTIKUMAR MRW403P 27 288 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
COMPARISON OF REGULATORY REQUIREMENTS AS PER USFDA &
EMA FOR DELAYED RELEASE AND EXTENDED RELEASE ORAL
FORMULATIONS AND COMPILATION OF MODULE 3 AND 5 AS PER
EMA
MR. KASHYAP THUMMAR
330 29-April-2019 172880827009 PATEL YAGNESHKUMAR VINODBHAI MRW403P 27 288 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
A STUDY ON REGISTRATION PROCESS OF RITUXIMAB INJECTION -A
BIOSIMILAR PRODUCT TO MabThera® AS PER EMAMR. FENIL SHAH
331 29-April-2019 172880827010 Shipra Vijayesh Pandey MRW403P 27 288 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
NALOXONE HCL NASAL SPRAY : DRAFT DOSSIER PREPARATION FOR
ANDS AS PER HEALTH CANADADR. ANAND SHAH
332 29-April-2019 172880827011 THAKKAR RAGHAV ATMARAMBHAI MRW403P 27 288 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
REGULATORY CONSIDERATION FOR IMPORT & REGISTRATION OF
HEMODIALYSER IN INDIA & EXPORT IN MEMBER COUNTRIES OF
ASEAN
MR. KASHYAP THUMMAR
333 29-April-2019 172880827003 DEVADHA MEHULBHAI RAJNIKANT MRW403P 27 288 MPPharmaceutical
Regulatory AffairsREGULATORY AFFAIRS
REGISTRATION OF AMLODIPINE TABLET IN USA & EU COUNTRIES
AND IMPLICATIONS FOR CHANGE IN EXCIPIENT CONCENTRATION DR. RAJESH PARIKH
334 30-April-2019 142240808013 PATEL VIVEK GANPATBHAI 940102 08 224 MP PHARMACEUTICSIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVING
FORMULATION AND EVALUATION OF MOUTH DISSOLVING FILM OF
ENALAPRIL MALEATEMRS SEJAL SOLANKI
335 25-April-2019 162240808010 PATEL PANKIL LALITBHAI 940102 08 224 MP PHARMACEUTICSDELAYED/EXTENDED RELEASE,
FLOATING, INSITU
FORMULATION AND EVALUATION OF SUBLINUAL TABLET OF
APREMILASTMR JAYANTI BAJAG
336 26-April-2019 162250808015 PATEL ROMA BHARATKUMAR 940102 08 225 MP PHARMACEUTICSIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVING
FORMULATION AND EVALUATION OF ORALLY DISINTEGRATING
TABLET OF TRIMEPRAZINEDR. SHAILESH T. PRAJAPATI
337 30-April-2019 162250808018 YOGENDRAKUMAR TIRATHRAJ MISHRA 940102 08 225 MP PHARMACEUTICSBUCO/MUCOADHESIVE, TDDS,
TOPICAL, HYDROGELS NASAL
FORMULATION AND EVALUATION OF BUCCAL FILM OF PRAZOCIN
HYDROCHLORIDEDR. HEMANGI J. PATEL
338 26-April-2019 162470808006 PATEL VIJAYKUMAR JAYANTIBHAI 940102 08 247 MP PHARMACEUTICSIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVING
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX
TABLETS OF PRAZOSIN HYDROCHLORIDEMR.ANIL RAVAL
339 26-April-2019 162520804003 PATEL JALAK VINUBHAI 940104 04 252 MPQUALITY
ASSURANCESTABILITY STUDIES
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPLC
METHOD FOR SIMULTANEOUS ESTIMATION OF BENIDIPINE HCI
AND CHLORTHALIDONE IN TABLET
MR M L KHARODIYA
340 26-April-2019 162560804005 PATEL DHAVAL SURESHBHAI 940104 04 256 MPQUALITY
ASSURANCESIMULTENEOUS ESTIMATION
DEVELOPMENT AND VALIDATION OF UV AND RP-HPLC METHOD
FOR SIMULTANEOUS ESTIMATION OF SAQUINAVIR DRUG IN BULK
AND PHARMACEUTICAL DOSAGE FORM
DR. BIRAJUBEN PATEL
341 30-April-2019 162640808007 TANK NITIN RAMESHBHAI 940102 08 264 MP PHARMACEUTICSIR, ODT, DT, SUBLINGUAL, FAST
DISPERSIBLE/DISSOLVING
FORMULATION AND EVALUATION OF QUICK DISSOLVING FILM OF
VENLAFAXINE HCI USING NATURAL POLYSACCHARIDES
MS. DHARMISHTHA A.
MOVALIA